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ABSTRACT 
Understanding the adaptive immune system poses a great conceptual challenge. It has evolved to 
respond to foreign invaders with exquisite sensitivity and selectivity. In particular, the T cell 
branch of the immune system is trained to distinguish between self and non-self This requires 
that a single receptor, the T cell receptor, bind to multiple ligands resulting in different cell fates, 
based in part on the avidity of the ligand. 
To address the question of ligand affinity discrimination in T cells, several T cell lines, both 
mouse and human, were screened for their ability to exhibit multiple cell fates in response to 
stimulation through the T cell receptor. A hybridoma system was identified that exhibits 
different levels of both apoptosis and cytokine production in response to three altered peptide 
ligands. 
We investigated how the consequent downstream signaling networks integrate to ultimately 
govern avidity-appropriate T cell responses in this hybridoma system. Here, we hypothesized 
that a quantitative combination of key downstream network signals can effectively represent the 
inforation processing generated by TCR ligation, providing a model capable of interpreting and 
predicting T cell functional responses. We generated a multivariate regression model fiom over 
1 100 signaling measurements that could predict IL-2 production in response, to a new ligand 
condition, implying that peptide avidity information is encoded in the magnitudes of downstream 
signals. Our model predicted a priori that IL-2 production is quantitatively related to both known 
and novel modulators, Erk and AM, with verification by subsequent inhibitor studies. 
Furthermore, the model could predict the non-additive effect of inhibiting both molecules 
simultaneously. These findings demonstrate the power of our quantitative systems modeling 
approach for numerical prediction of T cell responses fiom a key set of dynamic signals, and 
conceptual understanding of how complex signaling networks integrate information to translate 
pMHC stimuli into functional responses. 
To further analyze the relationship between Erk levels and IL-2 production in T cells, an epi- 
allelic series of stable Erkl and Erk2 knockdowns was generated. We show that both total and 
phospho Erk levels are correlated with IL-2 production and provide a framework for interpreting 
the phenotypes of partial knockdowns in other systems. 
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1. Introduction 
The immune system responds to and eliminates challenges from foreign invaders such as 
bacteria, viruses, and parasites. It consists of two branches: the innate immune system, which is 
nonspecific for any one pathogen; and the adaptive immune system, which exhibits pathogen 
specificity (Goldsby et al., 2000). Two major cell types are represented in the adaptive immune 
system: B cells comprise the humoral branch of the immune system and are capable of 
recognizing soluble antigen; T cells are part of the cell-mediated branch and generally recognize 
antigen in the context of self-cell presentation. T cells can be further divided into two classes 
based on the co-receptor which they express, either CD4 or CD8. The role of CD8 T cells is to 
recognize intracellular pathogens presented on self-cells, and therefore they often kill the self- 
cell presenting the antigen. CD4 cells recognize extra-cellular pathogen presented on self-cells. 
Their primary role is to activate other cell types of the immune system capable of clearing an 
infection. This thesis will focus on CD4 T cells (also called T helper cells). 
In the event of an immune response, activated CD4 T helper cells proliferate and assume an 
effector role. In most cases, this effector role results in the secretion of cytokines that mediate 
the immune response (Fig. 1.1 .). The nature of the immune response can vary, depending on the 
cytokine profile released by the CD4 T helper cells. This cytokine profile defines the class of 
CD4 T cells that is generated during the infection. CD4 effector T cells generally fall into two 
major classes, either TH1 (T helper 1) or TH2 (T helper2). TH 1 cells secrete inflammatory 
cytokines such as INF-y, IL-2, and TNF-p, capable of activating macrophages and cytotoxic T 
cells. A TH1 immune response is most effective on intracellular pathogens such as viral 
infections. TH2 cells secrete IL-4, IL-5, IL-10 and IL- 13; these cytokines activate B cells, 
resulting in an antibody dependent immune response that is most effective at clearing 
extracellular pathogens, such as some bacteria. However, in the initial stages of CD4 T cell 
activation, prior to the differentiation into either TH1 or TH2 effector cells, T cells produce the 
cytokine IL-2 which has been shown to be critical for the clonal expansion of T cells. Therefore, 
IL-2 is required at the very early stages of T cell expansion in addition to its role in TH1 cell 
effector function. Because of its role in the initial stages of T cell proliferation, IL-2 is often 
used as a primary readout for T cell activation and will be used as such throughout this thesis. 
CD4 T helper cells are activated by antigenic peptides bound to class I1 major 
histocompatibility complexes (p:MHC) expressed on antigen presenting cell (APC). Activation 
partially depends on the binding interaction of p:MHC and TCR. TCR binding to p:MHC can 
result in several possible cell fates correlated to the amount of TCR stimulation received: anergy 
(a state of unresponsiveness), activation and cell growth, proliferation or apoptosis. The idea 
that the T cell receptor was more than an onloff switch was first suggested in 199 1 when 
investigators found that the replacement of a glutamic acid residue with an aspartic acid residue 
within an antigenic peptide was capable of qualitatively altering the response of T cells. T cell 
stimulation with the endogenous peptide resulted in rapid T cell proliferation, while stimulation 
with the altered peptide ligand (APL) resulted in IL-4 production (Evavold and Allen, 199 1). 
Since then, great strides have been made in our physiological understanding of ligand 
discrimination behavior. 
Evidence suggests that the strength of TCR signaling, determined by the affinity of the 
TCR for the MHCIpeptide complex, plays an important role in T cell fate (Yun and Bevan, 
200 1 ). The TCR-peptide1MHC interactions exhibit a range of binding affinities, with Kd values 
ranging from 1 to 1 M. These are low values when compared to other biological 
ligand/receptor interactions, such as those between cytokines, growth factors, and their receptors. 
Therefore, the term avidity is often used to describe TCR interactions with peptide MHC 
complexes, since it takes into account both the cumulative number of interactions and the affinity 
of the interaction, which together can create a strong bond. 
The roles of weak and strong avidity TCR ligands in developing thymocytes has been 
well established (Yun and Bevan, 2001). In the thymus, T cells are selected specifically such 
that they recognize self-peptides with weak affinities. This is accomplished by selecting 
developing thymocytes with an affinity for self-peptide MHC while simultaneously selecting 
against autoreactive thymocytes with a high affinity for self-peptide MHC. Our understanding of 
weak and strong TCR-ligand interactions in the peripheral immune system is less clear. The 
significance of weak affinity interactions in the periphery has not been well established and there 
exists controversy as to whether weak affinity interactions are necessary for peripheral CD4 T 
cell survival (Clarke and Rudensky, 2000; Ohashi, 2002). In addition, peripheral T cell 
activation is largely dependent on co-stirnulatory signals provided by the CD28 receptor (Acuto 
and Michel, 2003). However, evidence from autoimmune disease models suggests that low 
affinity self-peptides may play a role in the capacity of T cells to tune their peptide-MHC 
responsiveness in the periphery (Illes et al., 2005). 
A major unanswered question in T cell biology is the molecular mechanism by which a 
population of clonal T cells can distinguish between various peptide sequences. T cells are so 
finely tuned that one amino acid change in the peptide sequence can significantly alter their 
response. This mechanism requires that the TCR complex be capable of sending multiple distinct 
signals resulting in different cell fates depending on the nature of the ligand encountered. 
Determining the primary mechanisms responsible for accurate ligand discrimination is 
complicated by the multiple interconnected pathways that are activated downstream of TCR 
ligation. 
To date, one of the challenges in addressing the ligand discrimination problem has been the lack 
of consistent data sets that take into account both multivariate and dynamic signaling 
information. Many studies have successfully focused on particular molecules or details of the 
signaling pathway to further our understanding of TCR ligand affinity discrimination. However, 
a systematic study of the TCR network activated under different TCR stimulation conditions has 
not been reported. Such a study is the goal of this thesis as it would provide insights into how 
multiple signaling pathways function in concert to regulate gene transcription of cytokines a 
critical fbnction of CD4 effector T cells. 
1. 1. Signaling Network structure in T cells 
Binding of the T cell receptor to a p:MHC molecule can result in multiple downstream signaling 
events including nuclear factor of activated T cells (NFAT), Akt, nuclear factor kappaB (NF-KB) 
and mitogen activated protein kinase (MAPK) activation (Fig. 1.2.) (Germain and Stefanova, 
1999: Huang and Wange, 2004). These molecules in turn activate or are themselves 
transcription factors capable of binding to the IL-2 promoter region and effecting a T cell 
response. Engagement of the T cell receptor activates the Src-family kinase Lck, which 
phosphorylates the immunoreceptor-based tyrosine activation motive (ITAM) sites on the CD3 
co-receptor. ITAM phosphorylation causes Zap-70 localization and activation resulting in the 
integral membrane protein Linker for Activation of T cells (LAT) being phosphorylated at 
multiple different tyrosines (Weber et al., 1998; Zhang et al., 1998; Zhang et al., 1999b). 
Phospho-LAT functions as a scaffold for various other signaling molecules including the adaptor 
protein growth factor receptor-binding protein-2(Grb-2), Grb2-related adaptor downstream of 
Shc (Gads), and phospholipase C y 1 (PLCy 1). 
Grb-2 recruitment to phosphorylated LAT leads to activation of the MAPK Erk and 
phosphatidylinositol-3 kinase (PUK), through Ras co-localization with the guanine nucleotide 
exchange factor (GEF), son-of-sevenless (Sos) (Buday and Downward, 1993). PLCy 1 cleavages 
phosphatidylinositol4,5-bisphosphate into inositol triphosphate and diacylglycerol (DAG). 
Inositol triphosphate stimulates calcium release for subsequent ~a++-dependent NFAT activation. 
DAG activates RasGRP (Ebinu et al., 2000) another Ras GEF, protein kinase C 0 (PKCO), the 
three MAPK (ERK, JNK, p38) pathways and Akt. Activation of the MAPKs results in activation 
of the transcription factor AP- 1. PKC 0 switches on the CARMA IBcl 1 O/IKB kinase (IKK) 
pathway leading to activation of the NF-KB transcription factor. Propagation of stimuli from the 
receptor results in eventual nuclear localization of AP- 1, NFAT, NF-KB, and Oct- 1 - 
transcription factors all of which are known to bind to the IL-2 promoter region (Jain et al., 
1995). 
2 Background on the known relevance of individual pathways in 
ligand affinity discrimination and 11-2 production 
This section will largely focus on the role of Erk and its upstream activator Ras in ligand affinity 
discrimination, since its role has been the focus of much of the recent research into ligand 
affinity discrimination. However, other pathways are activated in response to TCR ligantion and 
have been shown to be important for IL-2 production and background information on these 
pathways will also be provided. 
It is important to note that the ability of the TCR to interpret different affinity ligands could rely 
on either quantitative or qualitative differences in the activation state of the signaling network 
following TCR engagement and that these are not strictly independent. Quantitative difference 
can be thought of as changes in the magnitude of activation of downstream signaling molecules 
while qualitative changes would result in different signaling pathways being activated in 
response to different affinity ligands. Much of the evidence points towards quantitative 
differences in signaling resulting in different cell fate decisions (Mariathasan et al., 200 1; Werlen 
et al., 2003; Werlen et al., 2000; Yun and Bevan, 2001). However, several groups have also 
reported unique requirements of individual signaling molecules for particular cell fate decisions. 
In support of qualitative differences resulting in particular cell fates, the individual MAPKs have 
been uniquely implicated in T cell selection fates. Erk has been shown to be essential for 
positive selection while not required for negative selection (Alberola-Ila et al., 1995). 
Conversely, p38 and Jnk are important for negative selection (Rincon et al., 1998b; Sugawara et 
al., 1998). 
1.2.1. Regulation of Erk activation via Ras during TCR signaling 
The MAPK pathway is required for T lymphocyte differentiation (Alberola-Ila et al., 1995) as 
well as T cell homeostasis in the periphery (Priatel et al., 2002). Studies in mammalian neuronal 
(PC 12) cells have shown that the strength and duration of Erk activation is sufficient for 
determining cell fate decisions in these cells (Marshall, 1995). Recent studies indicate that 
strength and duration of Erk activation may play a similar role in both T cell development and T 
cell activation in the periphery (Werlen et al., 2003; Yun and Bevan, 2001). Studies have shown 
that the relative levels and duration of Erk activity changed in response to peptides that either 
induce negative or positive thymic T cell selection, two distinct cell fates (Mariathasan et al., 
200 1 ; Werlen et a1 ., 2000). 
It is possible that the regulation of Erk-activation dynamics are the result of tightly regulated Ras 
activation, both temporally and spatially. Ras is activated by TCR engagement (Downward et 
al., 1990) and can turn on various signaling cascades in response to T cell stimulation (Genot and 
Cantrell, 2000), most importantly, the Erk and PI3K pathways. Due to its well-defined role in 
both development and differentiation, Ras is a good candidate for regulation of T cell fate 
decisions. 
If Ras is to play a central role in Erk regulation and consequently T cell fate decisions, then Ras 
activation must either be quantitatively or qualitatively different when distinct ligands are 
encountered, and must result in the activation of different signaling pathways depending on 
ligand affinity. Recently, three specific mechanisms for modulating the effects of Ras signaling 
and consequently Erk activation in T lymphocytes have been described. Cells can use different 
Ras GEFs to both modulate how Ras signals and to determine on which membrane Ras is 
activated. In addition, scaffold proteins have been identified that regulate Ras signaling in yeast 
and mammalian cells by creating multi-enzyme complexes. 
Ras regulation by two GEFs 
Evidence that TCR signaling could lead to a change in the activation state of Ras was provided 
by Downward and colleagues (Downward et al., 1990). It was then subsequently recognized that 
Ras could be activated by two independent mechanisms (Izquierdo et al., 1992) in T 
lymphocytes. One mechanism required tyrosine kinase activity, the other could be triggered by 
addition of diacylglycerol (DAG, a major secondary messenger for T cell activation), and its 
pharmacological analogs, such as phorbol ester (Downward et al., 1990). The tyrosine kinase- 
dependent pathway activates Ras via the adaptor protein Grb-2 and the GEF Sos (Buday and 
Downward, 1993) in response to TCR stimulation (Buday et al., 1994). The diacylglycerol 
dependent pathway has only recently been defined with the discovery of a novel Ras GEF. This 
GEF, RasGRP (Ebinu et al., 1998), contains a diacyl-glycerol binding motif (Tognon et al., 
1998) and can be activated by DAG analogs. RasGRP is present at high levels in T lymphocytes 
(Ebinu et al., 2000), and is critical for T lymphocyte maturation and function (Dower et al., 
2000; Priatel et al., 2002). 
Evidence from knockout mice suggests the Ras GEFs, RasGRP 1 and Sosl, are important in 
determining the nature of T cell signaling downstream of the TCR. RasGRPl knockout mice 
have reduced numbers of CD4+ and CD8+ T cells. However, these cells show death rates similar 
to wild type T cells when challenged with self-peptides (Priatel et al., 2002), indicating that 
negative selection is not impaired in these mutant mice and that the T cell maturation block at the 
double positive stage is due to a defect in positive selection. This suggests that RasGRPl has a 
role in transducing signals from low affinity TCR ligands (Layer et al., 2003; Priatel et al., 
2002). Sos knockout mice are embryonic lethal and so far no T cell-specific knockout exists. 
However, we can infer from Grb2 deficient heterozygous mice that Sos is also a key molecule in 
T cell signaling. These mice exhibit reduced numbers of CD4+ and CD8+ T cells. When 
Grb2+/- T cells are challenged with self-peptide, they fail to die as efficiently as wild type T cells 
(Gong et al., 2001), indicating that negative selection may be impaired in these mice. This 
evidence suggests Sos and RasGRP are not redundant in activating Ras but rather that each GEF 
is responsible for transmitting distinct types of signals from the T cell receptor. Activating Ras 
through different GEFs provides a possible mechanism by which its activation could be spatially 
controlled determining T cell fate. 
Regulation of Ras signaling via selective activation at specific endomembranes 
Another potential mechanism for controlling the specificity of a signaling molecule is by 
restricting its subcellular localization. Ras is targeted to various cellular compartments including 
the ER and golgi (Apolloni et al., 2000; Choy et al., 1999) where activation can occur (Chiu et 
al., 2002; Choy et al., 1999). The microenvironment of these different membranes appears to 
affect both quantitative and qualitative aspects of Ras signaling, potentially by favoring 
recruitment of unique collections of Ras regulators and effectors. Therefore, restricting the 
localization of active Ras could contribute to TCR/ligand affinity discrimination. 
In T cells the two Ras GEFs that are activated downstream of the T cell receptor appear to 
activate Ras at different subcellular locations. Sos activates Ras at the plasma membrane 
(Holsinger et al., 1995), while RasGRP, a difhsible GEF, activates Ras preferentially on the 
Golgi and negatively regulates Ras at the plasma membrane in response to TCR engagement 
(Bivona et al., 2003). 
Activating Ras on specific endomembranes will result in qualitative differences in downstream 
signaling pathways if different effector molecules are recruited to specific endomembranes. 
Chiu and colleagues (2002) have recently provided evidence for qualitative changes in Ras 
signaling as a result of subcellular localization. Constitutively active Ras targeted to the ER was 
found to be a potent stimulator of the JNK pathway but did not activate either Erk or Akt (an 
indicator of PI3K activation); constitutively active Ras enriched on the golgi activated Erk and 
Akt but not JNK. In addition, evidence that Ras localization results in quantitative changes in its 
activation is suggested by the work of Bivona et al., (2003). Stimulating COS-1 cells with 
epidermal growth factor results in early, transient Ras activation on the plasma membrane 
followed by persistent, RasGRP dependent Ras activation on the Golgi (Bivona et al., 2003). 
Evidence in neuronal PC 12 cells, suggests that activation of Ras on the golgi is sufficient for 
cell differentiation. In these same cells, strength and duration of Erk (a Ras effector molecule) 
activation can determine cell fate (Marshall, 1999, potentially a mechanism which has also been 
proposed for determining T lymphocyte fate (Werlen et al., 2003; Yun and Bevan, 2001), linking 
the quantitative changes in Ras activation via localization to cell fate regulation. 
Ras regulation by tethering downstream effectors to Scaffold proteins 
One possible mechanism for cells to regulate the specificity of downstream targets is by 
employing scaffolding proteins (Burack and Shaw, 2000). Ras activation leads to the sequential 
activation of three downstream kinases: Raf (MAPKKK), MEK (MAPKK), and Erk (MAPK), 
were complexity and diversity in signals is created because multiple isoforms of each of these 
kinases coexist in T cells. The best understood scaffold proteins for the Ras pathway are in yeast 
where tethering kinases to a scaffold is sufficient for eliciting a specific cellular response after 
receptor stimulation (Park et al., 2003). 
A distinct scaffold protein, Kinase Suppressor of Ras (KSR) was identified in Drosophila and C. 
elegans as a protein necessary for Ras signaling (Kornfeld et al., 1995; Sundaram and Han, 1995; 
Therrien et a]., 1995). KSR associates independently with both Raf and MEK (Roy et al., 2002) 
in immuno-precipitation experiments suggesting a scaffold function for the MAPK signaling 
pathway downstream of Ras. 
A mammalian homolog of KSR was identified through a yeast two-hybrid screen (Yu et al., 
1998), and mouse knockouts of the KSR gene have been generated (Lozano et al., 2003; Nguyen 
et al., 2002). These mice have no defects in T cell development (Lozano et al., 2003). Both the 
spleen and the lymph nodes show no detectable differences fiom wild type mice in CD4 and 
CD8 T cell populations. However, T cells from KSR-I- mice stimulated via the antigen receptor 
do not proliferate as much as wild-type T cells and fail to produce IL-2 in response to TCR 
stimulation. Raf activation is not affected in KSR-I- thymocytes while Erk activation shows 
normal kinetics of activation, but lower levels of activity. This study suggests that KSR is not 
essential for T cell development. However, the proliferative defect in addition to lower Erk 
activity displayed by KSR-I- thymocytes does not rule out the possibility that KSR functions to 
catalytically enhance the MAPK pathway in T cells (Nguyen et al., 2002). 
Integrating the effectors of the Ras pathway 
Ras regulation via the Erk pathway may be key in distinguishing between quantitative ligand 
binding events in T cells that lead to distinct cellular responses. While evidence exists to support 
such a role for the Ras pathway in T cells, the mechanisms responsible for regulating Ras 
function in T cells remain incompletely defined, and evidence suggests that no single 
mechanisms is responsible for Ras acting as a branch point for signaling. Rather, T cells appear 
to use a combination of different mechanisms to control the activity of Ras and to define cellular 
fate in response to antigen stimulation. 
One potential integrated model for regulating Ras is through the phosphorylation of LAT at 
different tyrosines following TCR engagement resulting in the activation of distinct GEFs. The 
degree to which LAT is phosphorylated may be determined by the strength of TCR binding to 
MHCIpeptide, and this may affect which GEF is preferentially used. The GEFs in turn are 
capable of activating Ras at different endomembranes, which may differ in the types of 
downstream signaling molecules present, consequently altering the nature of the Ras signal. It is 
possible that scaffold proteins play a role in recruiting distinct collections of kinases to activate 
Ras and thus playing a potential role in modulating the outcome of Ras signaling in T cells. 
1.2.2. The P13K pathway 
That TCR ligation could result in the activation of PI3K was recognized over a decade ago 
(Ward et al., 1996). PI3K in T cells is activated through Ras and indirectly through PLCy. 
Active P13K results in membrane translocation of Akt through its PH domain (Vanhaesebroeck 
and Alessi, 2000) and its subsequent activation in T cells (Reif et al., 1997). While Akt does not 
directly activate a transcription factor that binds the IL-2 promoter region, there are several 
reported mechanisms by which Akt might regulate IL-2 production via its regulation of other 
transcription factors including NF-KB and NFAT. A constitutively active form of Akt has been 
shown to accelerate degradation of I K B ~ ,  resulting in increased translocation of NF-KB into the 
nucleus (Jones et al., 2000). Once in the nucleus, NF-KB can then bind to the IL-2 promoter 
resulting in 1L-2 transcription. Another Akt target is GSK3, a regulator of glycogen metabolism. 
GSK3 has also been shown to be a negative regulator of T cell activation through its regulation 
of the IL-2 transcription factor NFAT. Akt-dependent phosphorylation inactivates GSK3 
(Neilson et al., 200 1) resulting in nuclear translocation of NFAT. 
The role of PI3K in T cells has been studied using genetic knockouts. PDK is composed of a 
catalytic and regulatory subunit. In mammalian cells there are four genes encoding the catalytic 
subunit called p 1 1 Oa, p 1 1 OP, p 1 1 Oy, and p 1 1 06. There are two isoforms of the regulatory 
subunit of PI3K p85, p85a or p85y, which contain both the SH2 and SH3 protein binding 
domain. Another regulatory subunit, p 10 1, has been identified which contains a GPCR 
interaction domain and interacts with p 1 1 Oy. 
Mice targeting the regulator p85a subunit and the catalytic p l  1 Oy and p 1 106 subunits have been 
studied in T lymphocytes. The double knockout of the p100yl6 subunits has also been studied. 
Two groups have generated p85a knockout mice, showing that they do not have a T lymphocyte 
proliferation defect, but neither group has specifically examined IL-2 production in T cells from 
these mice (Fruman et al., 1999; Suzuki et al., 1999). In ex-vivo T cells from mice bearing an 
inactive form of p 1 106 antigen induced proliferation, Ca++ mobilization and IL-2 production is 
attenuated (Jou et al., 2002; Okkenhaug et al., 2002). T cells from a mouse lacking the pl  1 Oy 
gene also have T cell proliferation defects and reduced levels of IL-2 production in response to 
antigen stimulation (Sasaki et al., 2000). The p100y16 double knockout mouse exhibits defect in 
T cell development, however IL-2 production in stimulated T cells has not been examined 
(Webb et al., 2005). 
Genetic knockouts have also been generated for the three known Akt isoforms. Of the three Akt 
isoforms, Akt 1, Akt2, and Akt3, Akt 1 is the most highly and ubiquitously expressed isoform. 
Akt2 is also expressed in most adult tissues although at lower levels than Akt 1. Akt3 is 
expressed at the lowest level in adult tissue except for in the testis and brain. Akt 1 and Akt2 
knockout mice have been generated. Akt 1 knockout mice do not appear to exhibit severe T cell 
phenotypes although the ex-vivo T cell phenotype has not been determined (Chen et al., 2001); 
yet this isoform has been observed to localize to lipid rafts upon T cell activation (Bauer et al., 
2003) suggesting that it may function to transmit TCR signals. One potential interpretation of 
this data is that there is compensation of Akt 1 by Akt2 and Akt3. The role of the other Akt 
isoforms, Akt2 and Akt3 has not been looked at formally in T cells and it will be interesting to 
see if the three isoforms are hnctionally redundant for some cell decision processes. Given the 
complexity of the Akt pathway and the lack of T cell activation specific phenotypes in Akt 
knockout mice, the role of Akt in T cells is still not entirely clear. The lack of specific inhibitors 
to Akt has also complicated the interpretation of the role Akt has in transmitting TCR signals. 
P13K pathways appears to play a critical role in propagating TCR signals. However, PI3K has 
been shown to activate both PKC and Akt through PDKI. It remains to be seen whether Akt 
truly participates in regulating TCR signals, or whether the observations of its role in TCR 
signaling that have been obtained through the use of PI3K specific inhibitors reflect the role of 
PKC in activating downstream signals, since in addition to activating Akt, PUK downstream 
effectors may also activate some isoforms of PKC independently of Akt activation (Chou et al., 
1998; Le Good et al., 1998). However, another well established mechanism for activating PKCB 
in T cells is through PLCy {Nishikawa, 1 997 # 179). 
1.2.3. Calcium dependent signaling pathway 
NFAT positively regulates IL-2 gene transcription by translating cytosolic calcium levels into a 
nuclear transcriptional response. NFAT was first identified in 1988 (Shaw et al., 1988), and its 
role in 1L-2 transcription has been well established (Jain et al., 1995; Rao, 1994). The IL-2 
promoter contains two NFAT binding sites which can individually sustain promoter activity 
(Leiden et al., 1992), and NFAT activity has been shown to be required for IL-2 production 
(Chow et al., 1999). T cell receptor ligation results in activation of PCLy and subsequent release 
of calcium into the cytosol, which results in activation of calcineurin. Calcineurin is the 
phosphatase responsible for dephosphorylation and activation of cytoplasmic NFAT. Active 
NFAT then translocates into the nucleus where it functions as a transcription factor (Crabtree, 
2001). Our understanding of NFAT nuclear export is less well defined. GSK3 has been 
identified as a negative regulator of T cell activation and appears to be the kinase responsible for 
NFAT nuclear export. 
However, in addition to NFAT functioning as a positive regulator of IL-2 gene transcription, 
there are a couple of pieces of experimental evidence suggesting that certain isoforrns of NFAT 
may also fbnction to negatively regulate gene transcription (Lib 2005). Three different NFAT 
knockout mice have been generated that each do not express one of the three members of the 
NFAT family of transcription factors, NFATc, NFATp, and NFAT4. NFATc was knocked out 
by two independent groups and both show no IL-2 production defect in T cells from these 
knockout mice (Ranger et al., 1 998; Yoshida et al., 1998). T cells in NFATp and NFAT4 
knockout mice also do not have defects in IL-2 production. In addition these T cells have 
hyperproliferation and hyperactivation defects in response to TCR stimuli (Hodge et al., 1996; 
Oukka et al., 1998; Xanthoudakis et al., 1996). The lack of an IL-2 production phenotype in 
NFATc knockout mice suggests that there may be redundancy in the NFAT pathway. And 
indeed, a mouse deficient in both NFATc and NFAT4 exhibits decreased levels of IL-2 
production (Peng et al., 200 1). One possible explanation of the hyperproliferative phenotypes 
seen in NFATp and NFAT4 knockouts may be the allosteric effect of DNA binding. The authors 
in Giffin et al. (Giffin et al., 2003) speculate, that the DNA sequence to which NFAT is bound 
could potentially result in conformational changes in NFAT resulting in distinct protein-protein 
interactions which could lead to either activation or repression of the bound promoter region. 
In conclusion, there is little doubt about NFAT's role as a transcription factor capable of 
inducing IL-2 production; however, the role of individual NFAT proteins in IL-2 production is at 
this point difficult to determine possibly due to redundancy and compensation. In addition, 
evidence suggests that different NFAT isoforms play the more complex role as both positive and 
negative regulators of transcription. 
Studies of the IL-2 promoter have linked NF-KB to IL-2 production. The IL-2 promoter contains 
one NF-KB binding site and mutations in that region have been shown to negatively affect IL-2 
production (Garrity et al., 1994). The NF-KB transcription factor has been shown to play a 
critical role in T cell activation through its induction of genes that induce proliferation and 
cytokine production (Ghosh et al., 1998; May and Ghosh, 1998); however, the molecular 
mechanism by which NF-KB is activated and its role in different TCR mediated signaling events 
continues to be a topic of intense research. Recent work by multiple groups suggests that NF- 
KB activation is the result of PKCB recruitment to the immunological synapse followed by 
Carrna 1 /Bcl 1 O/Malt recruitment (Thome and Tschopp, 2003). The mechanism that potentially 
links PKCB, Carnal, and Bcll 0 was only recently proposed, with evidence that PKC 
phosphorylates the scaffold protein Carrnal resulting in the recruitment of BcllO and Malt to the 
membrane (Matsumoto et al., 2005). This in turn activates IKK resulting in the degradation of 
IKB and translocation of NF-KB into the nucleus (May and Ghosh, 1998). 
In krthering our understanding of the role of NF-KB in T cells and particularly in IL-2 
production, knockout studies have been very instructive. NF-KB in cells exists as a dimer of rel- 
family proteins. Of the five c-re1 family of proteins that have been knocked out in the mouse 
model system, p50 and c-re1 appear to have a role in mediating immune responses to pathogens 
(Ghosh et al., 1998). Knocking out the c-Re1 gene, whose expression is limited to the 
hematopoetic lineage, resulted in T cells unresponsive to TCR stimuli (Kontgen et al., 1995). 
Two groups have generated p50 gene knockouts (Sha et al., 1995; Weih et al., 1995). Both 
report that T cell function in p50 knockout mice is not significantly impaired but neither group 
reports IL-2 production levels in response to T cell stimulation. Sha and colleagues do report a 
defect in T cell proliferation in response to T cell activation. 
Additional complexity to understanding the role of NF-KB family proteins in IL-2 gene 
transcription comes fiom their reported dual function as both transcriptional activators and 
transcriptional repressors, depending on their dimerization state (Zhong et al., 2002). p50lp50 
homodimers have been shown to inhibit transcription, while p651p50 heterodimers have been 
shown to function as transcriptional activators. Therefore, evidence suggests that NF-KB family 
proteins can function as transcriptional activators of IL-2, but wether they do function as 
activators may depend more on cell context (Grundstrom et al., 2004). 
1.2.5. p38 and Jnk pathways 
The p38 and Jnk MAPK pathways are known stress response pathways that can mediate 
differentiation and cell death and have roles in T cell differentiation and development. Genetic 
studies have shown that p38 is important for at least two cell decision processes during 
thymocyte maturation and differentiation. Mice with a dominant negative form of p38 expressed 
from the lck promoter have severe T cell immunodeficiency - likely due to a block in the early 
stages of DN differentiation (Diehl et al., 2000). The same group of researchers has found that 
p38 appears to be important for Thl differentiation but not Th2 differentiation (Rincon et al., 
1998a). The functional role of p38 in ligand discrimination is complicated by the observation 
that activation is associated with negative selection of thymocytes (Sugawara et al., 1998). 
Not surprisingly, the role of p38 IL-2 production is also controversial. A couple of groups have 
suggested that p38 functions as a positive regulator of IL-2 production (Matsuda et al., 1998; 
Zhang et al., 1999a). There are also reports indicating that p38 may act as a negative regulator of 
IL-2 production following TCR stimulation (Kogkopoulou et al., 2006; Song et al., 2000; 
Veiopoulou et al., 2004). Finally, there are reports of p38 having little or no influence on IL-2 
production (Koprak et al., 1999; Mori et al., 1999; Schafer et al., 1999). It is possible that some 
of these contradictory findings are the result of intrinsic differences in mouse vs. human T cells. 
Two of the reports mentioned above use human primary T cells to show that a p38 specific 
inhibitor, SB203580, does not affect IL-2 production (Mori et al., 1999; Schafer et al., 1999) 
while a similar set of experiments in mouse primary T cells resulted in reduced IL-2 production 
(Zhang et al., 1999a). It is unclear what difference in molecular mechanism could account for 
these species-specific effects. And it is also possible that differences in the time of 
measurement between studies are reflecting differences in transient activation dynamics. 
Genetic studies have examined the role of Jnk in TCR mediated signaling including negative 
selection and Thl, Th2 differentiation (Dong et al., 1998; Rincon et al., 199813; Yang et al., 
1998). Mice expressing a dominant negative Jnkl fiom the lck promoter exhibit delayed 
negative selection (Rincon et al., 1998b). This same effect has not been observed in mice 
lacking the Jnk2 gene (Dong et al., 1998), indicating either that the two Jnk isoforms have 
different functions in negative selection or that Jnkl may be able to compensate for the lack of 
Jnk2. Consistent with the idea that the two Jnk isoforms have unique functions, studies fiom 
Jnk knockout mice indicate that Th2 differentiation appears to be negatively regulated by Jnkl 
(Dong et al., 1998), while Thl differentiation appears to be positively regulated by Jnk2 (Yang et 
al., 1998). 
Cell signaling studies indicate that Jnk may play several roles in TCR mediated signaling. These 
include phosphorylation of c-Jun increasing AP 1 transcription activity, and maintaining active 
NFAT in the nucleus. However, the role of Jnk in IL-2 production is still controversial. 
Evidence fiom studies examining the transcriptional activity of the IL-2 promoter has linked Jnk 
and subsequent cJun activity to IL-2 production (Jain et al., 1995). On the contrary, mice 
lacking both Jnkl and Jnk2 in peripheral T cells produced more cytokines, including IL-2 
following activation (Dong et al., 2000). 
1.3. Modeling the immune system 
There have been several recent, successful modeling efforts in immunology. In particular, 
modeling efforts have focused on trying to understand how the immune system attains its 
exquisite sensitivity, while remaining broadly specific to a wide range of pathogens, and capable 
of recognizing and tolerating itself (Goldstein et al., 2004). An antigen presenting cell displays 
on the order of lo5 - lo6 p:MHC molecules on its surface, only a small number of which will be 
pathogen derived. However, T cells are capable of recognizing as few as one antigenic peptide 
presented in the context of self-peptides (Irvine et al., 2002). In this case, two early modeling 
efforts suggested different mechanisms that could account for this sensitivity to agonist peptide: 
kinetic proofreading (McKeithan, 1995) and serial triggering (Chan et al., 200 1). There was 
experimental evidence to support both models; however, neither model could explain all the 
experimental evidence. A new model combining kinetic proofreading and serial triggering was 
proposed. This model could closely approximate more experimental data, providing a potential 
physical basis for explaining the sensitivity displayed by T cells to agonist peptides (Li et al., 
2004). 
It has been recognized that tremendous insight can be gained from attempting to understand the 
immune system in terms of physical phenomena through modeling (Chakraborty et al., 2003; 
Yates et al., 2001). By building a model that attempts to explain experimentally observed 
behavior, we can begin to understand the intricacies of a functioning immune system as well as 
the limitations of our current knowledge. There is a wide range of potential modeling 
techniques, ranging from biochemical reactions modeled by differential equations to purely 
statistical models that do not contain mechanistic information (Ideker and Lauffenburger, 2003). 
Any well-constructed model, ranging from mechanistic to statistical, should be capable of 
generating testable predictions. By determining when these model predictions are reflected by 
experimental evidence, we begin to codify our biochemical or statistical understanding of the 
functioning immune system. There is also a gain from model predictions that are not 
corroborated by experimental data; these indicate that the model can be improved and our 
biological understanding is incomplete. 
Membrane proximal events in TCR signaling are associated with very short time scales, and 
current models (Altan-Bonnet and Germain, 2005; Li et al., 2004) simulate activation only for 5- 
10 minutes. Increasing modeling time scales would allow the advantages of being able to 
include additional descriptors such as turning-off mechanisms, additional signaling molecules 
that have slower activation, and transcriptional feedback in the system. This kind of model 
would suggest additional experiments that address gaps in our current molecular understanding 
of signal transduction pathways. It could also provide additional information about molecules, 
such as the phosphatases that deactivate kinases in signal transduction pathways, that have not 
been well-studied due to experimental hurdles. Modeling can provide guidelines as to kinetic 
parameters the various phosphatases must possess in order to accurately describe observed 
kinase dynamics. In addition, models could shed light on molecules that exhibit slower activation 
dynamics, such as stress response molecules like p38, or nuclear translocation, which can only 
be captured by extending models out to longer simulation lengths, and ultimately provide a better 
representation of cellular responses. Early gene transcription can influence the state of 
intracellular networks by changing the cues (through autocrine signaling, see (Janes et al., 2005)) 
or the signals by upregulating specific intracellular molecules. These complex regulatory 
mechanisms will need to be understood in order to fully understand the diverse responses T cells 
exhibit post-activation. 
Figure 1.1. Cytokine secretion in T helper cells 
Two classes of CD4 effector cells can produce a range of cytokines capable of 
modulating the outcome of an immune response by activating subsets of other immune effector 
cells. The left half of a diagram is representative of a TH2 response, the right half is 
representative of a TH1 response. Figure Source: (Goldsby et al., 2000) 
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Figure 1.2. TCR signaling pathways 
Schematic diagram showing the various signaling pathways activated downstream of TCR 
ligation resulting in IL-2 production. 
2. Establishing a T cell system to quantify the activity of 
signaling pathways in response to TCR ligands that 
differentially induce either cell death or cytokine production. 
2. I. Introduction 
The engagement of the T cell receptor (TCR) by major histocompatibility molecules (MHC) and 
peptides can lead to multiple distinct cellular outcomes including proliferation, cytokine 
production, and cell death. How TCR engagement triggers distinct cellular responses is not 
completely understood. Current literature suggests that differences in the affinity of TCR ligands 
dictate the nature of induced TCR signals. At the cellular level, high affinity ligands in the 
periphery tend to induce proliferation, while low affinity ligands promote survival. An important 
question is: how does the TCR translate differences in the quality of ligands to the activation of 
distinct signaling pathways that result in different cellular responses? Addressing this question 
requires establishing an in vitro T cell system, capable of responding to different TCR stimuli. A 
key requirement for such an in vitro system is that different TCR stimuli elicit different cellular 
responses similar to T cell behavior seen in vivo. 
TCR signals are propagated intracellularly through six TCR-associated CD3 transmembrane 
proteins resulting in the activation of TCR-associated signaling pathways. In vivo, T cells are 
stimulated through the TCR by ligation with an MHC containing a peptide displayed on the 
surface of an antigen presenting cell. This stimulation can be mimicked in vitro, using a co- 
culture system where two cell types, a T cell and a cell expressing MHC molecules are 
combined, resulting in the T cell being stimulated through its TCR. T cells in vitro can 
alternatively be stimulated using an anti-CD3 antibody that acts as a surrogate stimulus for the 
TCR (Hara and Fu, 1985; Meuer et al., 1983; Oettgen et al., 1985; Weiss et al., 1984). In 
addition, pharmacological agents are available that mimic the release of downstream secondary 
messengers of T cell stimulation. This study focuses on using either anti-CD3 or peptide:MHC 
stimulation to differentiate between different cellular outcomes. 
Anti-CD3 can be presented to T cells in one of two forms: surface-bound or soluble. Anti-CD3 
can be surface-bound to either tissue culture wells or beads and may provide a unique signal to T 
cell for two potential reasons. First, surface-bound antigen can induce receptor aggregation and 
second, it can inhibit receptor internalization which has been shown to attenuate the signal 
(Valitutti et al., 1997). If stimulation with a different presentation of anti-CD3 leads to 
differences in cellular outcome, this would make a good system to answer the question of how a 
single receptor can induce different cellular phenotypes. Both human and mouse T cell lines are 
available that could potentially satisfy the requirements of the experimental system. I 
determined the feasibility of using two cell lines, one human T cell lymphoma cell line and one 
mouse T cell hybridoma. 
The H9 human lymphoma cell line has been used extensively for HIV related research and was 
cloned based on its ability to sustain HIV virus replication (Chen, 1992; Mann et al., 1989; 
Popovic et al., 1984). The H9 cell line presented an attractive possibility as an experimental 
system since it responds to TCR stimuli by producing IL-2 and its TCR related signaling 
networks have been previously successfblly studied. However, the specificity of its T cell 
receptor is not known. Therefore, the TCR of H9 cells is limited to stimulation by anti-CD3. 
The mouse T cell hybridoma cell line expressing the 1B6 TCR has been widely studied in the 
autoimmune disease model experimental allergic encephalomyelitis (Kuchroo et al., 2002). One 
appealing aspect of this cell line is its known TCR specificity. In the 1B6 cell line, one can 
examine the cellular response to endogenous TCR ligands, peptides presented on MHC 
molecules. 1 B6 T cells respond differently to altered peptides of myelin proteolipid protein 139- 
15 1. Three altered peptides have been shown to hierarchically affect proliferation, cytokine 
production and anergy in T cells containing the 1B6 TCR (Illes et al., 2005; Nicholson et al., 
1998). The stimulating proteolipid protein peptides contain a single amino acid substitution at 
position 144 from tryptophan to glutamine, tyrosine or leucine and they all bind MHC class I1 
with equivalent affinities (Nicholson et al., 1998). 
In this work, we analyzed the signaling dynamics and consequent cellular response of both cell 
lines stimulated with plate-bound vs. soluble anti-CD3 and 1B6 cells stimulated with peptide 
ligand. These findings indicate that H9 T cells alter their signaling dynamics in response to 
plate-bound vs. soluble anti-CD3. However, changes in apoptosis could not be detected making 
this an unsuitable experimental system to analyze the cue-signal-response paradigm. 1B6 cells 
showed both altered signaling dynamics and cellular responses to plate-bound vs. soluble anti- 
CD3 as well as to altered peptide ligands. Due to the physiological relevance of peptide TCR 
stimulation, we determined that 1B6 cells stimulated with altered peptide ligands of PLP was the 
ideal experimental system to study how information about ligand avidity is transmitted to 
through the signaling network. 
2.2. Materials and Methods 
Cell Culture Conditions 
H9 T lymphomas, DAS and 1B6 hybridomas were cultured in 1640 RPMI with Glutamine 
(VWR), 10% FBS (Hyclone, UT), Penicillin (1 00 unitslml) Streptomycin (1 00 pglml), Non- 
Essential Amino Acids (lx), HEPES (10 mM), and Sodium Pyruvate (1mM) (all Gibco) 
For soluble anti-CD3 stimulation, anti-CD3 (BD Biosciences; mouse 2C 1 1, human UCHTI) was 
diluted in cell culture media to the indicated concentration at the time of the experiment and 
added to 1B6 or H9 cells. For plate-bound anti-CD3 stimulation, anti-CD3 was diluted in PBS at 
the concentrations indicated and added to 24 well tissue culture plates. Plates were then 
incubated at 37 C for one hour up to overnight. PBS was removed and cell culture media 
containing 1B6 or H9 cells was added for time indicated. 
Peptide Stimulation and Lysis 
DAS cells (87.1 positive fibroblasts transfected with I-As) (Munder et al., 2002) were grown to 
confluence in 6 or 24-well tissue culture plates (VWR). 4144 (HSLGKQLGHPDKF), Y 144 
(HSLGKYLGHPDKF), L 144 (HSLGKLLGHPDKF) peptides (Anaspec) were added at 
concentrations indicated to DAS media 4- 12 hours prior to addition of T cells. 1B6 hybridoma 
cells were added to DAS plates, which were centrifuged at 1000 rpm for 1 minute, and incubated 
at 37C for time indicated. Supernatant was transferred to 4 volumes ice-cold PBS and 
centrifbged at 3000 rpm for 1 minute. The cells were lysed in lysis buffer containing 2% Triton 
X- 100,50 mM Tris-HC1 (pH 7.5), 150 mM NaCl, 50 mM P-glycerophosphate, 10 mM sodium 
pyrophosphate, 30 mM NaF, 1 mM benzamidine, 2 mM EGTA, 100 pM NaV04,l mM 
dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 10 pglml aprotinin, 10 pglml leupeptin, 1 
pglml pepstatin, 1 pglml microcystin-LR on ice for 20 minutes. After centrifuging at 14,000 
rpm for 10 minutes at 4OC, the soluble fraction of lysate was collected (cytosolic extract) and 
protein concentration determined using a Micro-BCA protein assay kit (Pierce). 
Western botting 
For SDS-page gel electrophoresis, lysates were generated as described above and diluted to 
either 2 mglml or 4 mglml. Alternatively, lysates were generated by stimulation with anti-CD3 
(BD Biosciences; mouse 2C 1 1, human UCHTI) and anti-CD28 (BD Biosciences; mouse 37.5 1) 
in serum free media. Reducing Laemmli-SDS sample buffer (Boston Scientific) was added, and 
samples were boiled for 10 minutes. After electrophoresis, samples were transferred to 
polyvinylidene difluoride membrane (Bio-Rad) and blocked with 3% BSA (Sigma-Aldrich) in 
TBST. Blots were visualized and quantified using the Kodak Image Station 1000. Anti-phospho 
p44/42 (Thr202/Tyr204), anti-phospho SAPKIJNK (Thr 1831Tyr 185), anti-phospho p3 8 
(Thr 180/Tyr182), anti-phospho Akt (Ser473) were from Cell Signaling Technologies, and anti- 
rabbit HRP from Santa Cruz Biotechnology. 
IL-2 ELISA 
Supernatant was collected after time indicated and analyzed for IL-2 concentrations using 
quantitative sandwich ELISA for mouse IL-2 (BD Biosciences). 96-well plates were read and 
analyzed using a SpectraMax 250 (Molecular Devices) at 450 nm with wavelength correction at 
570 nm. 
Inhibitor Screen 
The inhibitor library (Biomol, PA) was aliquoted and stored at -80 C. Inhibitor dilutions were 
carried out immediately prior to experiment in culture media. 150,000 H9 Cells were 
preincubated with inhibitor for one hour prior to CD3 or peptide stimulation. 
Antibody Staining for FACS 
200,000 cells were collected in 96-well round bottom plates and spun down at 1300 RPM for 5 
minutes. supernatant was removed and cells were washed two times with PBS containing 3% 
BSA. All wash steps in this protocol was followed by a 5 minute spin at 1300 RPM and a 
removal of the supernatant. Cells were then incubated in FC block (BD Biosciences, CA; clone 
2.462) diluted in PBS containing 3% BSA for 10 minutes on ice. Primary antibody was added 
at 1:200 in FC block solution and incubated on ice for 30 minutes. Cells were spun down and 
washed twice, as before. Cells were resuspended in 300ml wash buffer and analyzed on a 
FACScan (BD Biosciences, CA). Anti-CD28 (37.5 I), anti-CD4 and anti-TCR antibodies (H57- 
597) were from BD Biosciences, CA. For cell death assays Propidium Iodid was added to media 
immediately prior to FACS analysis. 
2.3. Results and Discussion 
2.3.1. Effects of soluble vs. plate-bound anti-CD3 stimulation on apoptosis 
and signaling dynamics in H9 cells 
To test whether H9 cells respond differently to plate-bound vs. soluble anti-CD3, a time course 
was generated with stimulation times up to one hour. This time course was then analyzed for the 
phosphorylation of Erk 112, p38, Jnk, and Akt (Fig 2.1 A). Phospho- Western blots indicate 
soluble anti-CD3 induces a stronger Erk and p38 response at early time points; Akt is 
phosphorylated only in response to soluble anti-CD3; and Jnk appears to be phosphorylated more 
strongly in response to plate-bound anti-CD3. 
To determine whether differences in the activation state of the signaling molecules correlated 
with a difference in cellular response, apoptosis was measured after 24 hours by propidiurn 
iodide incorporation in response to plate-bound and soluble anti-CD3 (Fig 2.1B). No clear 
trends were observed for differences in apoptosis to either plate-bound or soluble anti-CD3. 
Since no clear differences in cellular response could be observed in response to changing 
stimulation conditions, this cell line was not chosen for fwher analysis. 
2.3.2. Effects of soluble vs. plate-bound anti-CD3 stimulation on apoptosis, 
cytokine production and signaling dynamics in 1 B6 cells 
To determine whether the stimulation conditions of plate-bound vs. soluble anti-CD3 were 
capable of inducing different cellular outcomes in 1B6 cells, 1 B6 cells were stimulated with 
either plate bound or soluble anti-CD3. Apoptosis was determined 24 hours after anti-CD3 
stimulation by measuring propidium iodide incorporation (Fig. 2.2A). Cytokine production was 
measured by ELISA (Fig. 2.3D). Plate-bound anti-CD3 was able to induce both apoptosis and 
cytokine production. Apoptotic levels varied with anti-CD3 concentration leveling off at 0.1 
pg/ml. This leveling off could potentially be the result of all available receptor sites being 
occupied at that concentration. Soluble anti-CD3 did not induce either cell phenotype change. 
To determine whether differences in Erk signaling for plate-bound and soluble anti-CD3 could 
be detected, cells were stimulated and a time course from 0 minute through 60 minutes was 
generated. Western blots for phospho-Erk indicated that soluble anti-CD3 induced strong, 
transient Erk activation with a peak at 20 minutes and levels reduced from peak at 60 minutes 
(Figure 2.2B). Plate-bound anti-CD3 induced lower levels of Erk activation. Once Erk levels 
could be detected in plate-bound anti-CD3 stimulation, they appeared constant through out the 
60 minute time course. 
Although the 1 B6 system when stimulated with either plate-bound or soluble anti-CD3 exhibited 
two different phenotypic responses, which correlated with differences in signaling dynamics, we 
chose not to use this system in future studies for two reasons. First, a more physiologically 
relevant TCR ligand was available for the 1B6 TCR system. The 1B6 TCR is know to be 
specific for the myelin proteolipid protein peptide 139- 15 1 (Nicholson et al., 1998); Second, we 
were not able to quantifying the number of antibodies bound to the surface of the well and 
consequently the number of TCRs being stimulated per cell. This is because a plate-bound 
concentration refers to the concentration of antibody diluted in PBS that is used during the plate 
binding. The relationship between the concentration of antibody in solution vs. on the surface of 
the well is not known. Therefore, we could not make a direct comparison between stimulation 
levels of plate-bound vs. soluble antibody at different concentrations. 
2.3.3. Co-stimulation does not appear to affect the phenotypic response of 
1B6 cells to TCR stimulation 
Co-stirnulatory molecules, such as CD28, provide an important second signal to naive T cells 
resulting in T cell activation in the periphery (Liu and Janeway, 1992). To determine whether 
1B6 cells expressed the co-stimulatory ligand CD28, its surface expression was measured using 
FACS. CD28 expression could be detected at low levels in a control cell line, mouse DO1 1 (Fig. 
2.3A). CD28 could not be detected on the surface of 1B6 cells using FACS (Fig. 2.3A). Both 
DO1 1 and mouse lB6 cells appear to express TCR molecules on the cell surface at similar levels 
(Fig. 2.3B). 
To exclude the possibility that CD28 levels presented at the cell surface of 1B6 cells are below 
the detection limit of FACS analysis, functional CD28 stimulation assays were preformed. 
CD28 co-stimulation is known to enhance the effects of TCR stimulation, therefore, 1B6 cells 
were stimulated with either plate-bound or soluble anti-CD3 with or without a stimulating form 
of anti-CD28. Cell death was measured by propidiurn iodide incorporation. IL-2 was measured 
using ELISA. Co-stimulation through the CD28 receptor did not appear to affect either apoptosis 
(Fig. 2.3C) or IL-2 production (Fig. 2.3D) in 1B6 cells. From these studies we concluded that 
CD28 does not appear to be present on the surface of 1B6 cells. 
2.3.4. Signaling dynamics of the PLP peptide system in the 1 B6 and DAS 
cell lines 
To determine the effects of individual peptides on signaling dynamics, lB6 T cell hybridomas 
were stimulated with Q 144, Y 144 or L 144 peptide and the activation state of Erk, Jnk, p-38, and 
Akt, was measured by western blotting at multiple time points after peptide stimulation (Fig. 
2.4A). L144 induced the strongest Erk and Jnk signal, at 30 minutes, with a graded response for 
Y 144 and 4144. p38 activation appeared to increase with time for all conditions measured while 
Akt phosphorylation was highest in the Y peptide stimulation condition. 
In the above experiment, 1B6 cells were stimulated with DAS cells, fibroblasts transfected with 
I-AS and B7.1 (Munder et al., 2002). One potential confounding variable of generating lysates 
from suspension T cells stimulated by adherent APCs is the contamination of the T cell lysate 
with APCs. To determine whether DAS cells respond to the addition of peptide and 1B6 T cells 
by upregulating the activation state of their signaling molecules, DAS cell lysates were generated 
and probed by western blotting for Erk, Jnk, p-38, and Akt (Fig 2.4B). Western blots indicate 
that the activation state of the MAPKs and Akt does not change in response to peptide addition 
and T cell stimulation. Since DAS cells do not change their activation state in response to 
peptide addition and T cell stimulation, the effect of DAS cell contamination would result in a 
dilution of the signal. However, we make the assumption that DAS cell contamination is low 
and relatively constant across samples. 
Since 1B6 cells show a graded response to altered peptide ligand (APL) stimulation, data in later 
chapters will be generated using the 1B6 PLP system. 
2.3.5. Inhibitor screen identifies key signaling components of IL-2 
production in response to TCR stimulation 
To identify key signaling components downstream of the T cell receptor required for IL-2 
production, an inhibitor library, containing 67 kinases and 14 phosphatase inhibitors (see 
Appendix A, Supplementary Fig. 1) was screened. The library contained multiple inhibitors 
targeting the same compounds and its specificities reflected a broad range of molecules 
identified in the literature to be downstream of TCR signaling. 
To identify molecules relevant for IL-2 production in T cells, H9 cells were pre-incubated with 
the compounds in the inhibitor library at two different concentrations, 10 pM and 10 nM for 60 
minutes, then stimulated with anti-CD3 for 6 hours. IL-2 production was measured via ELISA 
(Fig 2.5A). Several inhibitors for the same target were consistently identified as capable of 
reducing IL-2 levels. These include inhibitors to the Akt signaling pathways (Wortmanin and 
LY0294002), Erk signaling pathways (PD98059 and U0126) 
Multiple proteins previously described as being important in TCR signaling emerged as 
regulators of IL-2 production in these experiments. However, experimental variability was 
significant between these experiments. In addition, the concentration of inhibitor used was 
constant and did not reflect the potency of any individual inhibitor. To address these limitation, 
21 inhibitors were selected (Appendix A, Supplementary Fig. 2) based on their IL-2 inhibition 
profile and an additional screen was performed at greater than or equal to five times the ICso for 
each inhibitor (experimental inhibitor concentrations are indicated in Appendix A, 
Supplementary Fig. 2). This screen was performed on 1B6 cells stimulated with L144 peptide 
for 6 hrs. IL-2 was measured by ELISA (Fig 2.5B). Most notably, some inhibitors targeting Src 
family kinases, MAPKs (with the exception of p38), NFkappaB, PUK, and PKC potently 
reduced 1L-2 production in 1B6 cells stimulated with L144 peptide. These molecular targets are 
expected to inhibit IL-2 production since they result in the activation of known IL-2 transcription 
factors (Jain et al., 1995). The PI3K pathway, which among other pathways activates AM, has 
not been directly implicated in activating an IL-2 transcription factor in the absence of co- 
stimulation. However, 1 B6 cells treated with the PI3K inhibitor exhibited reduced IL-2 levels. 
Interestingly, different inhibitors targeting the same molecule or different molecules in the same 
pathway did not affect IL-2 production equally (Fig 2.5B). One example of this are the two Src 
kinase inhibitors, PP 1 and PP2 which appeared to have very different effects on IL-2 production. 
Also, of the three inhibitors targeting calcineurin, molecules upstream of NFAT activation, none 
of them reduced IL-2 production by greater than 25%. This finding is unexpected due to NFATs 
well defined role in IL-2 production (Ullman et al., 1990). 
Taking into account the results of the inhibitor screen, further analysis of the network state 
downstream of T cell activation will determine the activation state of multiple signaling 
pathways including the MAPKs, Erk. P38, and JNK; Akt; NFAT; and NFKB. 
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Figure 2.1. H9 cells stimulated with plate-bound vs. soluble anti-CD3 
A) H9 lysates probed for indicated phosph-species. B) Percent live cells after 24 hrs. stimulation 
with plate-bound filled squares) or soluble (open squares) anti-CD3 as quantified by propidium 
iodide incorporation and FACS analysis. 
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Figure 2.2. 1B6 cells stimulated with plate-bound vs. soluble anti-CD3 
A) Percent live cells after 24 hrs. stimulation with plate-bound vl led squares) or soluble (open 
squares) anti-CD3 as quantified by propidium iodide incorporation and FACS analysis. B) 
Detailed time course of phospho-Erk activation following anti-CD3 stimulation. 
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Figure 2.3. CD28 co-stimulation does not alter the 1B6 phenotypic response 
to TCR stimulation 
A) and B) Surface expression of CD28 and TCR respectively as assessed by FACS analysis the 
DO1 1 cell line is used as a positive control for CD28 staining. Shown are negative controls for 
DO1 1 and 1B6 cells (Filled histograms) and stained DO1 1 (black outline) and 1 B6 cells (gray 
outline). C) Percent live cells after 24 hrs. stimulation with plate-bound (filled symbol) or soluble 
(open symbol) anti-CD3 and with (triangle) or without anti-CD28 (square) as quantified by 
propidium iodide incorporation and FACS analysis. D) Cumulative IL-2 levels produced in the 
absence (squares) or presences (triangles) of plate-bound (filled symbols) or soluble anti-CD3 
(open symbols). 
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Figure 2.4. 1B6 cells respond differently to stimulation with altered peptide ligands 
of PLP 
A) Time course of phospho-protein activation in 1B6 cells stimulated with peptide 
ligand. B) Time course of phospho-protein activation in DAS cells antigen-presenting 
cells during 1 B6 peptide stimulation. 
Figure 5 A. 
1 TYRPXOSTIE 9 AC-679 
At -1c96  
AG- a110 
CIP 5079 
hC- I2 E 
RW-SOIPS 
&C- 41 4 
~ H O S T I I C  r3 
TWHOSTIB 4'1 
TllRPHOST IE 4 6  
ZM 33637: 
TYRFHDSTIIO 25 
110 1aDb IE 
L -p -BROKOTETRAEI 3 OLE OX AL ATE 
TTB.P#OSTIE 5 1  
35ELT MIETlW IS 
GEf ISTE IB 
SB-=035BO 
r$ArnZErn  
ZE 'b4sbc9 
US ,649 ICWLORO-1-beta-D-RIBOFUR1LBOSYLBE 
A f  -b:l 
S- ImBTMERC ID IS 
IIlD IR88 In-3  ' -B?OBOOX IELE 
STAlJROSPORIBE 
TYRHTOST IE A 6  1478 -1.0 1: 1 1.0 
PP 1 
'fPRFH0ST 110 AG 1Z95 
913149 6 
Fold 
FEWIMZRATE 
HA-1004 Change 
e inn- 
Figure 5 B. 
- ""I 
t 
Figure 2.5. Screening for signaling pathways that control IL-2 production 
following TCR stimulation 
A) Relative levels of IL-2 produced by H9 cells in response to the inhibitors indicated. 
IL-2 levels are normalized to DMSO control. H9 cells were pre-incubate with either 10 
nM (I and II or 10 pM (111 and IV) of inhibitor and stimulated with anti-CD3. B) Levels 
of IL-2 produced by 1B6 cells in response to the inhibitors indicated. Individual 
inhibitors were diluted to the concentrations indicated in Appendix B. 
3. Network Signal Combinations Downstream of T Cell Receptor 
Activation Predict IL-2 Response 
3.1. Introduction 
Signaling through the T cell receptor (TCR) leading to cell decision processes is determined 
in part by the affinity of the T cell receptor for its ligand. Affinities of TCR/ligand 
interactions can differ by at least three orders of magnitude (Lanzavecchia et al., 1999) and 
can correspondingly elicit vastly different cellular responses. In mature T cells, high-affinity 
TCR-pMHC interactions can lead to T cell activation whereas low-affinity interactions are 
important for cellular homeostasis and may be involved in antigenic signal amplification. 
Activation of T cells by altered peptide ligands (APLs) can also induce partial activation, 
hyperstimulation and anergy (Gascoigne et al., 2001). Elucidating the complex molecular 
details underlying ligand affinity discrimination by T cells is central to our understanding of 
both T cell-mediated immunity to pathogens and immune dysfunctions, such as 
autoimmunity and aberrant irnrnunosu~eillance. A growing body of work has focused on 
proximal TCR signaling events in order to elucidate mechanisms of ligand affinity 
discrimination (JCrogsgaard and Davis, 2005). However, recent work in other areas of cell 
biology has ascertained that quantitative combinations of signals in downstream pathways, 
distal to the initiating receptor activation, may better represent the receptor-mediated 
information governing ultimate cell phenotypic responses (Hautaniemi et al., 2005; Janes et 
al., 2005; Prudhomme et al., 2004). In the context of post-TCR activation, we provide 
evidence that multiple activation states quantitatively encoded by the signaling network 
define regulatory aspects for a T cell cytokine response. 
Differential signals from TCR binding can result &om single residue changes occurring at the 
ligand-receptor interface. Upon TCR engagement, changes in the ITAM phosphorylation 
patterns (Madrenas et al., 1995; Sloan-Lancaster et al., 1994) activate multiple interconnected 
signaling pathways (Germain and Stefanova, 1999; Huang and Wange, 2004) (illustrated in 
Fig. 2A). Propagation of stimuli fiom the receptor results in eventual nuclear localization of 
AP-I, NFAT, NF-KB, and Oct-1 - transcription factors, all of which are known to bind to the 
IL-2 promoter region (Jain et al., 1995). For this reason, IL-2 production is often used as a 
measure for T cell activation. 
In this study we employed a high level modeling approach (Ideker and Lauffenburger, 
2003; Janes and Lauffenburger, 2006), partial least squares regression (PLSR) analysis, to 
understand the relationship between ligand avidity, downstream signaling dynamics, and IL-2 
production. This type of analysis can relate a data-set of predictor variables (signaling 
measurements) to a response variable (IL-2 production) without prior knowledge of - or 
assumptions about - network structure. This method of linear multi-variate statistical 
modeling has been used successfblly to understand signal-response relationships in cell 
decision processes such as apoptosis (Gaudet et al., 2005; Janes et al., 2005; Janes et al., 
2004). 
3.2. Methods 
Generation of hybridoma 
The 1B6 T cell hybridoma was generated in the laboratory of Vijay Kuchroo by fusion of the 
1 B6 T cell clone (Nicholson et al., 1998) with the TCR negative fbsion partner BW1100. 
Following fusion, positive hybrids were identified by measuring growth inhibition in the 
presence antigen presenting cells and L144 peptide versus control peptide. Positive cells 
were subcloned using limiting dilution at least twice. 
Lysis preparation 
DAS cells (B7.1 positive fibroblasts transfected with I-As) (Munder et al., 2002) were grown 
to confluence on Nunc coated omni trays (Nunclon). Q 144 (HSLGKQLGHPDKF), Y 144 
(HSLGKYLGHPDKF), L144 (HSLGKLLGHPDKF) peptides (Anaspec) were added at 
concentrations indicated to DAS media 4-12 hours prior to addition of T cells. 1 o7 1B6 
hybridoma cells were added to DAS plates, which were centrifuged at 1000 rpm for 1 minute, 
and incubated at 37C. supernatant was transferred to 4 volumes ice-cold PBS and 
centrifuged at 3000 rpm for 1 minute. The cells were lysed in buffer (Janes et al., 2003) 
modified to 2% Triton X-100 on ice for 20 minutes. After centrifuging at 14,000 rpm for 10 
minutes at 4OC, the soluble fraction of lysate was collected (cytosolic extract) and protein 
concentration determined using a Micro-BCA protein assay kit (Pierce). The pellet was 
resuspended in 420 mM NaCl, 20 mM HEPES (pH 7.9), 1mM EGTA (pH 8.0), 1 mM EDTA 
(pH 8.0), 1 mM sodium orthovanadate, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl 
fluoride, 10 pdml aprotinin, 10 pglml leupeptin, 1 pglml pepstatin, 1 pglml microcystin-LR. 
The pellet was sonicated for 1 min followed by 3 minutes on ice, repeated 6 times, followed 
by centrifugation at 14,000 rpm for 30 minutes at 4C. 
Inhibition 
PD098059 and LY294002 (DMSO stock), and AktX (water stock) (all Calbiochem) was 
diluted to working concentration in media. 1B6 cells were preincubated in PD098059 for 30 
minutes; LY294002 for 30 minutes and AktX for 1 hour, prior to stimulation with peptide- 
loaded DAS cells. 
Quantitative western blotting 
For SDS-page gel electrophoresis, lysates were diluted to either 2 mglml or 4 mglml, 
reducing Laemmli-SDS sample buffer was added, and samples were boiled for 10 minutes. 
40 pg or 80 pg lysate was loaded per well. Each sample was loaded in triplicate wells and 
for normalization purposes, each gel contained duplicate lanes of a positive control sample. 
After electrophoresis, samples were transferred to polyvinylidene difluoride (PVDF) 
membrane and blocked with 3% BSA in TBST. Blots were visualized and quantified using a 
Kodak Image Station 1000. The net intensity of individual bands was determined and 
normalized to the net intensity of the average of the positive control bands. Triplicates were 
then averaged and fold activation determined by normalization to the zero time-point. Anti- 
phospho ~44142 (Thr202/Tyr204), anti-phospho SAPWJNK (Thr 1 83lTyr 1 85), anti-phospho 
p38 (Thr180/Tyr182), anti-phospho Akt (Ser473) were from Cell Signaling Technologies, 
and anti-rabbit HRP from Santa Cruz Biotechnology. 
Kinase activity assays 
MAPKAPK2 (MK2) and IKKalP activities were determined by a custom multi-plex kinase 
assay (Janes et al., 2003) with the following modifications: For the MK2 assay, Protein A 
microtiter strips (Pierce) were coated with anti-MK2 (Stressgen), and the reaction allowed to 
proceed for 1 hour. For the IKKalpassay, 500 pg of total lysate protein was incubated in the 
antibody-coated wells overnight. Data were normalized by the value quantified for the zero 
time-point for fold-activity. 
NFA T westerns 
NFAT phosphorylation and localization was measured by resolving 22 pg of sample protein 
(boiled for 10 minutes in sample buffer) on 5% polyacrylamide gel, alternating cytosolic and 
nuclear fractions in the lanes. Membranes were blocked with 3% BSA in TBST followed by 
incubation with NFATc2 antibody (Santa Cruz Biotech) at a 1:500 dilution. Ratios of 
dephosphorylated bands to phosphorylated bands on the same lane were determined. 
IL-2 ELISA 
Supernatant was collected after 4 hours and analyzed using quantitative sandwich ELISA for 
mouse IL-2 (BD Biosciences). 
Data processing and modelling 
The compiled data matrix was transformed by the equation y = loglO(x+l) where x is a 
measured value, to account for a skewed distribution of experimentally measured values. The 
column transformed data were then mean-centered and scaled by unit variance. Partial least- 
squares regression analysis was performed in SIMCA-P (Umetrics). The data-set was 
divided into two matrices: Y E R15x' consisting of IL-2 measurements, and 
x ~ 1 5 x 5 7  denoting the measured protein signals. The PLSR algorithm successively finds 
linear combinations of the predictor variables that have maximum covariance with the 
response variables, so that each linear function is uncorrelated with previous ones (Wold et 
al., 2001). PLSR can accommodate data-set that are not fully complete (i.e., yielding 
matrices that are not of full rank), provided the missing values are randomly distributed 
across the different observations, e.g. JNKl and JNK2 data points are missing in one of three 
experimental replicates for each stimulation condition. For more detailed description on 
PLSR modeling we refer to a previous explication (Wold et al., 2001). 
3.3. Results 
3.3.1. Peptide avidity defines cellular response 
In T cells containing the 1B6 TCR, the three altered peptides we use have been shown to 
affect proliferation, cytokine production and anergy hierarchically (Illes et al., 2005; Kuchroo 
et al., 2002; Nicholson et al., 1998). The altered peptide ligands (APLs) are based on the 
autoantigen myelin proteolipid protein peptide 139-1 5 1 but contain a single amino acid 
substitution at position 144 from tryptophan to glutarnine, tyrosine or leucine. All three 
peptides bind MHC class I1 with equivalent affinities (Nicholson et al., 1998). We assayed 
apoptosis induced by different concentrations and avidities of APLs in T cell hybridomas 
(Ashwell et al., 1987) that express the 1B6 TCR. DAS antigen presenting cells were pulsed 
with proteolipid protein APLs Q 144, Y 144, and L144 for 4- 12 hours prior to addition of 1 B6 
cells. After 24 hours, apoptosis of 1B6 cells was measured via propidium iodide 
incorporation (Fig. 3.1A). Prior experiments with Annexin V and propidium iodide double 
staining confirmed that cell death through peptide stimulation occurs by apoptosis (Appendix 
B, Fig. 1). 1B6 cells stimulated with L144 peptide showed greater than 85% cell death at 
both peptide concentrations measured, the Y 144 peptide induced 53% cell death at 4 pg/ml, 
while the Q144 peptide at 4 pg/ml induced cell death at levels similar to the no peptide 
control (Fig. 3.1 A). 
The levels of IL-2 production in 1B6 cells stimulated with the various peptides 
correlated with the apoptotic responses (Fig. 3.1B). IL-2 production was measured after 4 
hours of peptide stimulation. High levels of IL-2 were present in the media of 1B6 cells 
stimulated with L144 peptide and low levels of IL-2 were present in the media of 1B6 cells 
stimulated with the Y 144 peptide. IL-2 in the supernatant was below the detection limit in 
cells stimulated with 4144 peptide. Since apoptosis within a sample will affect the 
cumulative IL-2 produced by that sample, we avoid confounding effects between two 
phenotypic behaviors, IL-2 production and apoptosis, by measuring signaling dynamics and 
cellular responses in the first 4 hours post-activation. 
3.3.2. Peptide avidity determines activation dynamics of downstream 
signaling molecules 
To determine how the avidity of the TCR for the pMHC is encoded within these signaling 
pathways, we measured the activation levels of key signaling molecules known to be 
important for IL-2 production in T cells (highlighted molecules in Fig. 3.2A). Of the IL-2 
promoter elements, we measured the nuclear translocation of one directly (NFAT), and 
measured activation/phosphorylation of kinases upstream of others (IJSKalP for NF-KB, JNK 
for Jun, ERKll2 for Fos, and p38/MK2 as an additional surrogate of the AP-1 component 
ATF-2). To generate a self-consistent, multi-variate data-set (Gaudet et a]., 2005; Janes et al., 
2003), all protein activation measurements (Fig 3.2A) were obtained fiom a single lysate 
containing in excess of 40 x lo6 cells per stimulation condition and time-point. The endpoint 
cellular response measurement was the level of IL-2 production acquired fiom media 
collected in the plate at 4 hours. In total, we measured for 5 peptide stimulation conditions 
and one no peptide control condition for the following: 1 1 predictor signals at 6 time-points, 
and one response variable (IL-2) at the final four-hour time-point. To account for biological 
variation within the data-set, each stimulation condition was replicated on three different days 
and triplicate experiments were entered into the model as separate observations (Fig. 3.2B). 
In a few cases, we were unable to accurately quantify signals on a lysate (Fig. 3.2B, gray 
squares). The final data matrix contained 1 178 unique measurements. To our knowledge, this 
is the f ~ s t  time that such a large array of signals has been analyzed systematically and 
concurrently for a clonal TCR line activated by peptide ligand-stimulation. 
Examples of the dynamic time-courses of these signaling measurements are illustrated 
in Figs. 3.2C in which the replicate time-course measurements for ERK2 and Akt are each 
compared across the three different peptides all at a concentration of 4 pg/ml. We show that 
in all three peptide stimulation conditions, ERK2 and Akt are activated during the measured 
time course and that levels and timing of activation vary with peptide. Lysates generated 
fiom the antigen presenting cells after co-culture with the 1B6 T cells show no contribution 
to activation signals (Appendix B, Supplementary Figure 3A). We surmise that - within the 
context of this experimental system - individual altered peptides do not appear to elicit 
qualitatively unique signatures in network dynamics but rather mainly affect the magnitude of 
phosphorylation/activation of the signaling molecules sampled. 
3.3.3. Information content of data-set is sufficient for IL-2 fitting within 
the training set data 
Our objective in this work was to explore the hypothesis that IL-2 production is encoded 
within an appropriate set of measurements of dynamic signaling in the network downstream 
of TCR activation. If the levels of IL-2 production are indeed encoded within the signaling 
dynamics then it is feasible to construct a model capable of predicting the IL-2 production 
(response variable) data in Figure 2B fiom the signaling (predictor variables) data. 
The model converged at two principal components; attempts to identify additional 
principal components did not yield greater information content (Appendix B, Supplementary 
Fig. 2A), following statistical criteria described (Wold et al., 2001). The two-component 
model is capable of fitting IL-2 concentrations fiom the input data with a line y = 1 .19~  +
0.06 and a regression coefficient (defined as R ~ Y  - see Methods section) of 0.97. PLSR 
creates the principal components through linear combinations of the predictor variables. In 
highly-connected biological pathways, non-linearities may be present in the system. We 
examined the potential benefit of including non-linear terms to the model as described 
previously (Janes et al., 2004), but these further terms did not enhance the model's ability to 
explain data variance; in fact, they decreased the regression coefficient by amplifying noise in 
the data matrix (data not shown). 
When individual samples are mapped onto the two principal components via their 
scores, IL-2 producers can be discriminated from non-IL-2 producers on the first component 
(Fig. 3.3A). IL-2 producers scored positive on the first component while non-IL-2 producers 
scored negative on the first component. A two-tailed Welch's t-test (df = 13) comparing the 
first principal component loadings between IL-2 producers and non-IL-2 producers 
demonstrates statistical significance (p = 0.0008). The second principal component loadings 
are not significantly different between the two groups. This finding suggests that the 
combination of signals comprised in the first component are largely responsible for binary 
control of IL-2 production fiom on to off, while the combination of signals comprised in the 
second component are more responsible for fine-grained tuning of IL-2 production. 
Therefore, it becomes of immediate interest to ascertain which signals are heavily weighted 
in one or the other component, for this may aid in deciphering which if any particular signal 
is involved in "onJoff' control or "tuning" of IL-2 production. Predictor signaling variables 
were plotted onto the two principal components based on their weighted contributions to the 
component (Fig. 3.3B; Table 3 .I). Signals with large values influenced the model to a greater 
extent than signals that were close to the origin, while signals with negative values were 
inversely related to the response variable (Fig. 3.3B; the complete mapping of signal weights 
is provided in Appendix B, Supplementary Fig. 2B). Similarly, signals that mapped close to 
the IL-2 response were more heavily relied upon for IL-2 fitting than signals that were close 
to the origin. Both ERKl and ERK2 at multiple time-points were heavily weighted (Fig. 
3.3B; Table 3.1). This is anticipated, as ERIC is thought to be a major contributor to cellular 
outcome in response to TCR signaling. More surprisingly, Akt also emerged as a primary 
contributor for both the first and the second components (Fig. 3.3B; Table 3.1). Although Akt 
is known to contribute to co-stimulation, a key role in transducing TCR signals has not been 
reported. The 1B6 cell line does not show changes in IL-2 when CD28/CTLA-4 is blocked 
with a CTLA-4/Fc fusion protein. In addition the 1B6 cell line does not shown changes in 
apoptosis levels in response to anti-CD3 in combination with anti-CD28 compared to anti- 
CD3 alone, suggesting that the observed influence of Akt in the model is due to primary TCR 
signaling (Appendix B, Supplementary Figure 3B and C). JNK scored highly on both the 
first and the second component and its contributions to IL-2 prediction appeared to at least 
roughly co-localize with NFAT (Appendix B, Supplementary Figure 2B); this may reflect an 
established molecular mechanism that JNK can directly activate NFAT-driven transcription 
(Ortega-Perez et al., 2005). In addition we found a close correlation between ERK signals 
and IKK signals (Appendix B, Supplementary Figure 2B). To the best of our knowledge no 
mechanism of cross-talk between these pathways under antigen-receptor stimulation 
conditions has been reported. However, this tight correlation could reflect a common origin 
of activation of both pathways, such as by PKCB. 
3.3.4. Information content of signals is sufficient for a priofl IL-2 
prediction of a new stimulation condition 
We sought to determine whether the biological information captured in the model is capable 
of predicting IL-2 production for a new stimulation condition. 1B6 T cells were treated with a 
new condition, 0.04 pglml L144 peptide, and the protein signaling variables were input into 
the model (Fig. 3.4A). The model was then used to predict IL-2 production based upon the 
signaVresponse relationships derived from the trained model. Figure 3.4B shows the linear 
regression fit between experimentally measured 11,-2 values and thefirted model IL-2 values 
for the trained model described by Fig. 3.2B (black, blue, green, red symbols). On the same 
graph, the experimentally measured IL-2 values versus the predicted IL-2 values (yellow 
symbols) is plotted for the data in Fig. 3.4A. The model performs very successfully for two of 
the samples, predicting IL-2 concentrations within 2% and 18% of the experimentally 
measured values. For the third sample, model performance was less tight but nonetheless 
predicted IL-2 concentration to within a factor of 2. 
To investigate whether a model trained on measurements of a single signaling protein 
(with full time-course; Fig. 3.5A, B) or at a single time-point (across the full set of proteins; 
Fig. 3.5C, D) could adequately predict IL-2 production, we constructed different models from 
restricted subsets of our data. We evaluated the quality of each model by three metrics: the 
fit to IL-2 (R~Y;  a value near 1 is desired), the fraction of variation in IL-2 measured by cross 
validation (Q~Y;  a value near 1 is also desired), and the sum of errors in the three apriori 
predictions (ZDmodY; a value near zero is desired). 
The optimal full model exhibited a value of 0.94 for R ~ Y ,  0.57 for Q ~ Y ,  and 2.04 for 
ZDmodY. By comparison, the best-performing single-protein model arose from that 
constructed on ERK2, with an R ~ Y  of 0.81 (Fig. 3.5A, B). All other single-protein models 
performed worse than the ERK2 model. Although Akt had been found to be a primary 
informer in the full model, an Akt-only model performed poorly by itself, producing an R ~ Y  
of 0.62. We can conclude then that a satisfactory model relating signals downstream of TCR 
activation to IL-2 production requires a quantitative combination of measurements across 
multiple pathways. This conclusion is reasonable in light of the necessity for multiple 
transcription factors regulated by the diverse pathways to bind in combinatorial fashion to the 
IL-2 promoter region. 
To address the inclusion of time-course data, models were also constructed across the 
signaling proteins at a single time-point (Fig. 3.5C, D). The large number of t=30 minutes 
variables identified to be heavily weighted in the fill model suggested that a model using 
only 30-minute measurements of the 11 signaling proteins might perform well. An R ~ Y = O . ~ O  
was indeed found for a model containing only 30-minute predictor variables, but the 
predictive ability of the model was low as evidenced by the large value of CDmodY=7.5 1. 
Models built using other single time-points performed better than the t=30-minute model for 
ZDmodY, but at the expense of a lower R ~ Y .  Clearly, inclusion of measurements at multiple 
time-points was required for optimal model prediction capability. These simulation results 
indicate that predictive information encoded in the various signaling pathways may differ 
temporally in kinetic rates of propagation of information relevant to IL-2 production. 
Therefore, we conclude that to most effectively capture the critical features of network 
operation, dynamic measurements are required. 
3.3.5. Akt phosphorylation level is informative of IL-2 production 
We have thus far demonstrated that models built upon a single signalling molecule or time- 
point do not contain enough information to fully capture the IL-2 response. We next asked 
whether a single signal (such as the top-weighted Erk and Akt) might nonetheless be capable 
of modulating the IL-2 response in a predictive manner as long as multi-variate relationships 
among pathways are maintained. Because Erk has a well established role in propagating 
K R  signals and is heavily weighted on the first component, we examined the predicted 
effect of inhibiting Erk on IL-2 production. In addition, we examined the predicted effect of 
inhibiting Akt on IL-2 production because the optimal model relied especially heavily on Akt 
in both the first and the second components. Simulated time-courses were generated by 
computationally reducing the levels of either Erk or Akt phosphorylation by 25%, 50%, or 
75% across all time-points while keeping all other predictor variables unchanged (Fig 3.6A 
and C). We modified four signalling time-courses: two L144 4 pgiml observations used in 
the training set and two L144 0.04 pglml observations used in the npriori prediction. The 
PLSR model was then used to predict IL-2 production for the new observation based upon 
the altered Erk or Akt signals (Fig. 3.6A and C). Reduced IL-2 production levels were 
predicted to be tightly correlated with both reduced Erk and reduced Akt phosphorylation, 
described by a slope of -0.29 for Erk and -0.84 for Akt. Reducing Erk and Akt levels by the 
same degree simultaneously led to a surprising prediction in that the decrease in IL-2 was 
slightly less than the sum of the individual signal contributions (Fig 3.6E, slope = -1.0 vs - 
1.12) 
To test these model predictions, we experimentally measured IL-2 levels under 
conditions of Erk and Akt inhibition using small molecule inhibitors and compared these 
values to the corresponding PLSR model predictions. An experimental dose-response curve 
was created for inhibition of Erk by PD98059 and Akt by LY294002 (Appendix B, 
Supplementary Fig 4). PD98059 is specific for the Erk pathway, and inhibits the upstream 
activator of Erk, Mek. LY294002 targets Akt indirectly through PDK. 1B6 cells were pre- 
incubated with either PD98059, LY294002, or a combination of the two, followed by a 30- 
minute stimulation with 4 pglml L144 peptide. Cell lysates were analyzed for 
phosphorylation state of the inhibition target. PD98059 was found to inhibit Erk 
phosphorylation with an of 0.7 pM for ERKl and 3.1 pM for ERK2. Akt 
phosphorylation was inhibited by LY294002 with an ICso of 1.3 pM. To assess the effect of 
reduced Erk activity on IL-2 production, we inhibited Erk phosphorylation levels by 
concentrations 0.6, 1.7, and 5 pM based upon the above determined dose response and 
measured 4 hour IL-2 production under these conditions (Fig. 3.6B). As expected, we 
observed a tight correlation between measure 1L-2 levels and Erk inhibition levels, described 
by a slope of -0.58 (Fig 3.6B). Similar experiments using the Akt inhibitor LY294002 at 25, 
50 and 75% inhibition (0.5, 1.3, and 5.2 pM respectively) validate the model-predicted 
dependence of IL-2 production on Akt phosphorylation levels, with an experimental slope of 
-1.22 (Fig 3.6D) quite consistent with the predicted slope of -0.83.(Fig 3.6C) Most 
importantly, the decrease in IL-2 due to the combination of ERK and Akt inhibitors resulted 
in a slope experimentally measured slope of -1.36 (Fig 3.6F), less than the sum of the 
individual contributions as predicted by the model (Fig 3.6E). 
3.4. Discussion 
Through our examination of TCR ligand discrimination, we provide new insights as to how a 
receptor communicates information about a ligand-binding event to an interconnected 
signaling network and subsequently integrates these signals in the nucleus through multiple 
transcription factors. We chose a TCIUAPL system that is optimally suited for our studies 
due to a multiple-ligand repertoire that can alter the magnitude of response; the cytokine 
output was selected because of the well-defined IL-2 promoter region and the detailed 
knowledge of its transcription factor recruitment. Capturing the multiple activation states 
generated by a signaling network through an appropriate computational model has been 
shown to be an especially effective approach to understanding complex biological 
information processing (Janes et al., 2005). Previous work on ligand discrimination has 
focused on molecules proximal to the TCR; by moving downstream of TCR-proximal events 
we have gained a better understanding of how the consequent dynamic state of the TCR 
signaling network integrates molecular activation dynamics to govern an important T cell 
phenotypic response. One obvious next step is to understand how TCR-proximal events 
propagate to quantitatively determine the dynamic network state. Another beckoning line of 
inquiry is to test whether our dynamic network state approach can help gain further 
understanding of related T cell phenomena, such as co-stimulation (Kroczek et al., 2004) and 
TCR degeneracy (Nicholson and Wraith, 2004). 
Our findings emphasize the crucial requirement for combinatorial contributions of 
dynamic signaling pathways to ligand affinity discrimination. We were motivated to measure 
time-courses by previous reports indicating the importance of ERK dynamics in cell decision 
processes (Marshall, 1995) including T cell development and h c t i o n  (Altan-Bonnet and 
Germain, 2005; Mariathasan et al., 2001; Werlen et al., 2000). Our modelling iterations 
demonstrate the information gain by inclusion of multiple time-points. Furthermore, the 
biological significance of multiple transcription factors converging at the IL-2 promoter is 
reflected by the enhanced predictive power of a model consisting of multiple pathways 
simultaneously compared with a single molecule model. This suggests the potential 
increased efficiency of multi-target modulation of IL-2 for anti-inflammatory therapeutics 
and graft rejection. 
Akt is not known to directly activate the known IL-2 transcription factors, however, 
through computational modelling a novel finding emerged, that Akt phosphorylation levels 
could accurately predict an IL-2 response in context of the other key principal component 
signals in a similar manner to a known regulator of IL-2, ERK. Significantly, the model was 
able to predict a cancelling effect between ERK and Akt that prevented IL-2 from being 
reduced further with the combinatorial inhibition of both pathways.It is possible that our 
results in which Akt emerged as a major indicator of TCR-induced IL-2 production are due to 
the concerted influence of Akt on NF-KB, NFAT, and AP-1 activation (Diehn et al., 2002; 
Jones et al., 2000; Jones et al., 2005; Kane et al., 2001; Kane et al., 1999; Patra et al., 2004; 
Schade and Levine, 2004), consistent with our findings that combinatorial contributions of 
signaling pathways determine a cellular decision process. 
Table 3.1. Largest variable influences on the projection. 
Values are determined by the weighted sum of squares of the loading coefficients taking into 
account the explained variance of IL-2 in each component dimension. 
peptide avidity 
(conc. in pglml) 
peptide avidity 
(conc. in pglml) 
Figure 3.1. Altered peptide ligands elicit hierarchical cellular responses 
(A) Percent live cells as quantified by propidium iodide exclusion 24 hours post-stimulation 
with control (black symbols), 4144 peptide at 4 pglml (blue), Y144 peptide at 4 pglml 
(green), and L144 peptide at 0.4 and 4 pglml (red). (B) Cumulative IL-2 levels produced 4 
hours post-stimulation as detected in culture media under the same conditions as A. Error 
bars represent standard deviations of triplicate ELISA measurements on a single sample. 
Peptide stimulation conditions including the no peptide and Q144 conditions were measured 
by triplicate experiments. 

- 8 4 0 4 0  
PC 1 scorns 
no peptide 0144 
Y144 L144 
PC 1 weights 
0 ERKl ERK2 . Akt 
Figure 3.3. PLSR modeling can distinguish cues and signals associated with IL-2 
production through a reduction in dimensionality 
(A) The scores plot of the contributions of individual experiments to the trained model 
separates experimental conditions that produce IL-2 from those that do not. Symbol colors 
are control (black symbols), Q 144 peptide at 4 pg/ml (blue), Y 144 peptide at 4 pg/ml (green), 
and L144 peptide at 0.4 and 4 pglml (red). (B) The loading scatter plot of weights projects 
the response variable, IL-2 (large red diamond), on the same plot as the contributions of a 
subset of predictor variables, ERK1, ERK2, and Akt signals. Refer to Appendix B, 
supplementary figure 3B for the full set of variable weights. 
Modeled IL-2 (nglml) 
B 
MK2 IKK 038 ERKl ERK2 JNKl JNK2 JNK3 Akt cNFAT nNFAT 11 2 
Figure 3.4. Prediction of a new stimulation condition with the trained model 
(A) Heat map of the signals from new observations used for prediction. Color scale and data 
processing is identical to Fig 2B. (B) Fitted versus measured IL-2 production for the trained 
data (black, blue, green, and red symbols representing control, Q 144, Y 144, and L 144 
peptide respectively) and predicted data (yellow symbols). Error bars represent standard 
error of the predicted values as calculated by the sum of squares of the residuals of the 
training data divided by the number of observations - 1. 
Figure 3.5. Iterations of modeling using subsets of X variables indicate that no model 
outperforms others for all descriptors 
(A and C) Regression coefficients (R~Y) and cumulative fraction of the total variation in IL-2 
(Q~Y). (B and D) Deviation from regression line as calculated by the root square distance 
summed across the three apriori observations. A and B depict single protein models across 
all time-points. C and D depict single time-point models across all proteins measured. 
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Figure 3.6. Validation of the correlative relationship between Erk or Akt 
phosphorylation and IL-2 production as suggested by PLSR 
(A,C,E) PLSR prediction of decreasing Erk (A) Akt (C) or Erk and Akt phosphorylation 
levels simultaneously (E). Levels are modified to 75%, 50% and 25% of the original value, 
while all other signals are maintained at their original values. Predicted IL-2 values of 
modified data are normalized to fitted IL-2 values of unadulterated data reported in Fig. 4B. 
(B,D,F) Experimental measurements of IL-2 in response to L144 4pg/ml peptide in the 
presence of PD90859, LY 294002, or PD98059 + LY294002 inhibition on Erk and Akt 
phosphorylation. Error bars represent +I- standard deviation of triplicate experiments, except 
(F) which represents 2 experiments. 
4. Generation of an epi-allelic series of Erkl and 2 knockdowns for 
the quantitative analysis of Erk regulation and IL-2 production 
4.1. Introduction 
TCR cross-linking is known to result in the activation of Erkll2 (MAPK 112) through Ras 
(Izquierdo et al., 1992). In T cell receptor signaling, Ras can be activated by one of two guanine 
nucleotide exchange factors, Sos and RasGRPl. Ligand binding to the T cell receptor causes 
multiple proteins to localize to the membrane bound Linker for activation of T cells (LAT) 
including PLCy and Grb2 and become phosphorylated. RasGRPl is recruited to the membrane 
by PLCy-dependent cleavage of PIP2 to diacylglycerol and IP3. Sos is recruited to the 
membrane by Grb2 binding to LAT. Ras subsequently activates the Raf-MEK-Erk cascade. 
Once Erk is activated, it functions to transmit the TCR-induced signal further downstream to the 
IL-2 promoter. Erk activation has been shown to be necessary for Jun and Fos complex to form 
the AP- 1 transcription factor which, among other transcription factors, binds to the 1L-2 
promoter resulting in IL-2 production (Dumont et al., 1998; Li et al., 2004; Whitehurst and 
Geppert, 1 996). 
Erk dynamics have been implicated in determining T cell fate. Sustained versus transient Erk 
dynamics have been observed in nayve T lymphocytes corresponding to positive and negative 
selection, respectively (Werlen et al., 2000). Furthermore, the duration of Erk signaling appears 
to influence CD4+CD8+ lineage commitment (Nishida et al., 2004). Multiple mechanisms have 
been postulated to generate these differences in Erk dynamics. Recently, a positive feedback 
loop in which Erk phosphorylates Lck in a regulatory manner to prevent SHP-1 deactivation of 
Lck was shown to sustain TCR signaling (Stefanova et al., 2003). Mathematical modeling efforts 
have demonstrated how the balance between this novel Erk positive feedback and negative 
feedback via phosphotase-mediated deactivation of molecules proximal to the TCR allows for 
sensitivity in ligand discrimination (Altan-Bonnet and Germain, 2005). A downstream positive 
feedback loop between Erk-mediated immediate early gene (IEG) expression and Erk has also 
been described (Murphy et al., 2002). The combination of the multiple feedbacks both upstream 
and downstream of Erk could account for cellular sensitivity to these MAPK molecules. 
With the intense focus on MAPK activation mechanisms and its kinetic parameters (Murphy and 
Blenis, 2006), the independent roles of Erkl and Erk2 in T cell activation are still not well 
understood. Pharmacological inhibitors employed to study Erk influences in cellular signaling 
cannot distinguish between the two isoforms because they act upon their common upstream 
kinase MEK. Embryonic lethality of Erk2 (Saba-El-Lei1 et al., 2003) has prevented studying this 
molecule in isolation, but also suggest independent roles for Erkl and Erk2 because Erkl cannot 
fully compensate for the loss of Erk2. Conversely, Erkl knockout mice are viable, but display a 
phenotype of decreased thymocyte maturation beyond the double-positive stage and a weak 
proliferative response to TCR stimulation (Pages et al., 1999). Individual conditional deletions 
of Erkl and Erk2 demonstrated that neither protein is needed for the transition from double 
negative to double positive T cells, however Erk2 is necessary for positive selection for mature 
CD4+ or CD8+ cells (Fischer et al., 2005). 
Prior work demonstrated a correlation between Erk dynamics and the IL-2 cellular response (CH 
3, this thesis). A statistical model based upon multiple kinase signals distal to the TCR and 
upstream of 1L-2 promoter elements was heavily dependent on Erk -- in the context of other 
TCR-activated molecules -- in its ability to predict IL-2 production for peptides of varying TCR 
avidity. In addition, despite the above cited evidence of differences in functional roles of the 
Erkl/2 isoforms for development, the model attributed similar correlations of Erkl and Erk2 in 
IL-2 production, suggesting functional redundancy. 
Taken together, these observations regarding Erk activation and function lead us to the 
hypothesis that IL-2 production in response to TCR stimulation by T cells may be very sensitive 
to cellular Erk levels. To test this hypothesis, we generated an epi-allelic series (Hemann et al., 
2003) of Erkl and Erk2 stable shRNA knockdowns. These knockdown cell lines enable the 
detailed examination of the relationship between total Erk, phospho-Erk, Erk activity and IL-2 
secretion resulting in a quantitative understanding of the individual contributions of different Erk 
parameters to IL-2 production. By analyzing eight Erk knockdown cell lines, we have 
determined that there is a strong relationship between Erk, phospho-Erk and IL-2 levels. This 
graded relationship between Erk levels and IL-2 production provides promise as a means for 
modulating inflammatory response through therapeutic design on a single molecular target. 
The epi-allelic series also allowed for examination of how individual Erk isoforms contribute to 
a cell decision process. Through analysis of the range of Erkl and 2 knockdown levels, we 
conclude that in the context of a T cell hybridoma cell line, Erkl and Erk2 contribute similarly to 
both Erk activity and IL-2 production. 
Generation of stable knockdown cell lines 
Replication-deficient lentivirus was produced in 293FT packaging cells (Invitrogen) as described 
previously (Rubinson et al., 2003). The pLKO. 1 vector and shRNA sequences were obtained 
from the RNAi Consortium (Moffat et al., 2006). 48 hrs after transfection viral Supernatants 
were collected, filtered through a 0.45 micrometer filter and used for infection immediately or 
stored at 4C for several days. 10' 1B6 hybridoma cells were spin-infected with viral supernatant 
in 24 well-plates for 1.5 hrs at 2500 rpm at 30C in the presence of 8 microgram/ml polybrene. 4 
hrs after infection fresh media was added and cells were grown at 37C for 48 hrs. To eliminate 
uninfected cells, puromycin (2.5 microgramlml) was added to the cells for additional 5 days. 
Cells were maintained in puromycin-containing media. 
Semi-quantitative western blotting 
2x10~ cells were resuspended in 200 pl media without FBS. For stimulated samples, 2 pglml 
anti-CD3 (2C 1 1, BD Biosciences) was added for 10 minutes at 37C. Cells were then lysed and 
boiled for 5 minutes in Lammeli reducing sample buffer. 10 p1 of each sample was load per 
well. After electrophoresis, samples were transferred to polyvinylidene difluoride (PVDF) 
membrane and blocked with 3% BSA in TBST. Blots were visualized and quantified using a 
Kodak Image Station 1000. The net intensity of individual bands was determined and 
normalized to the net intensity of the average of the positive control bands. Triplicates were then 
averaged and fold activation determined by normalization to the zero time-point. Anti-total and 
anti-phospho p44142 (Thr202lTyr204) antibody was from Cell Signaling Technologies, and anti- 
rabbit HRP from Santa Cruz Biotechnology. 
To determine the level of protein knockdown for each cell line was determined intensity of each 
Erk band was first normalized to its tubulin control. This normalization accounts for differences 
in protein loading from one sample to another. To account for differences in intensity across 
multiple membranes, both Erk bands across a single membrane were then individually 
normalized to the corresponding Luciferase control band. The standard deviations reported are 
representative of both biological and experimental replicates. 
Kinase activity assay 
Erk activity was determined in simulated (2 pgml anti-CD3 was added for 10 minutes at 37C) 
and un-stimulated samples by a custom multi-plex kinase assay as described in (Asthagiri et al., 
1999; Janes et al., 2003). Myelin basic protein (Sigma) was used as the substrate in the in vitro 
reaction. CPM was background corrected and normalized by pg lysate protein per well as 
determined by micro-BCA assay (Pierce). To account for cell line variation in basal activities, 
the stimulated lysate value for each cell line was normalized by its respective unstimulated value 
prior to dividing by the luciferase value. 
IL-2 ELISA 
Supernatant from 100,000 1B6 cells stimulated for 4 hours on DAS cell (Munder et al., 
2002)seeded- L 144 peptide coated- 24-well plates was collected and analyzed using quantitative 
sandwich ELISA for mouse IL-2 (BD Biosciences). 
4.3. Results and Discussion 
4.3.1. Generating a range of stable Erkl and Erk2 knockdown cell lines 
To determine whether total Erk levels could be modulated using established shRNA techniques, 
four unique sequences in both Erkl and Erk2 mRNA transcripts were targeted for knockdown in 
mouse 186 T cells, generating an epi-allelic series for both Erkl and Erk2. Stable cell lines were 
generated for each shRNA using lenti-viral infections and puromycin selection. As a non- 
specific control, stable cell lines were generated by infection with shRNAs targeting Luciferase. 
The level of total protein knockdown for each sequence was determined by western blotting (Fig. 
1A). Normalized Erk levels are reported (refer to Methods). 
For Erkl , a range of knockdowns from 12% (Erkl -A 1 1) to 96% (Erkl-B 12) was generated (Fig. 
4.1A); for Erk2, a range of knockdowns fi-om 49% (Erk2-G5) to 85% (Erk2-G7) was generated 
(Fig. 4.1A). These results deomstrate the ability to generate a range of stable knockdowns using 
shRNA constructs of differing target sequences. 
To determine whether one Erk isoform was being up-regulated in the presence of an shRNA to 
the other Erk isoform, the level of the knockdown isoform was plotted against the total 
cumulative level of both Erkl and Erk2 (Fig. 4.1C). Given the linear relationship of Erk2 
knockdowns to total Erk levels, no compensation was seen in Erk2 knockdown cell lines. On the 
other hand, Erk 1 knockdown cell lines did appear to partially compensate for the loss of Erkl by 
increasing ErkZ levels in strong Erkl knockdowns. This compensatory effect is surprising given 
the larger absolute abundance of Erk2 versus Erkl in wild-type cells. 
4.3.2. Total Erk levels correlate with IL-2 production 
To determine whether there is a direct correlation between total Erk levels and IL-2 production 
in response to TCR stimulation, 1B6 ErklIErk2 knockdown cell lines were stimulated with 
4pgIml of L 144, an altered peptide ligand of PLP, presented on surrogate antigen presenting 
cells (Munder et al., 2002). IL-2 production was measured four hours after peptide stimulation 
by ELISA. Both Erkl and Erk2 levels were positively correlated with IL-2 production (Fig. 4.2). 
This result is not unexpected, given the role Erk has been shown to play in TCR lignad 
discrimination (Altan-Bonnet and Germain, 2005). 
4.3.3. Phospho-Erk levels correlate with total Erk levels and approximate 
IL-2 levels 
To determine the relationship between an Erk knockdown and its associated phospho-Erk levels 
upon stimulation, stable knockdown cell lines were stimulated using anti-CD3 and phospho-Erk 
levels measured via immunoblotting then normalized as described above (Fig. 4.3A). By 
comparing total-Erk levels to phospho-Erk levels in these knockdown cell lines (Fig. 4.3B), we 
observe, with the exception of a single outlier, a positive correlation between the two 
measurements, suggesting that a constant fraction of the Erkl and Erk2 present in these cells is 
activated in response to stimulation. 
Since phospho-Erk levels are expected to be a more relevant predictor of IL-2 levels, the 
relationship between phospho-Erk levels and IL-2 was determined (Fig. 4.3C). Both phospho- 
Erkl and Erk2 levels appear to closely correlate with IL-2. These results suggest that there is a 
dose-dependence of phospho-Erk for IL-2 production and that IL-2 levels can be modulated 
through Erk activation. 
4.3.4. Understanding the relationship between Erk phosphorylation and its 
activity 
Aggregate Erkl/2 activity in knockdown cell lines was determined for both stimulated and 
unstimulated cells via a kinase activity assay. Normalized Erk activity is reported here (refer to 
Methods). When comparing phospho-Erkl and Erk2 levels in Erkl and Erk2 knockdown cell 
lines respectively, both Erkl and Erk2 phosphorylation levels correlate with Erk activity (Fig. 
4.4A). Similar trends emerge when summed phospho-Erkl and 2 are plotted for each cell line 
(Fig. 4.4B, r2 = 0.86). This result is not unexpected, as phospho-Erk is often reported as a 
surrogate for Erk activity; however in light of the stable knockdown cell lines this indicates a 
lack of compensation by the unaltered isoform. In addition, it is interesting to note, that in this 
system Erkl and Erk2 appear to contribute similarly to total Erk activity, with attempts to 
account for relative cellular protein levels of the two isoforms (1 :2 ratio Erk l :Erk2) resulting in a 
lower regression coefficient (?=0.73). 
Erkl and Erk2 knockout mice have different phenotypes (Saba-El-Lei1 et al., 2003), and 
conditional Erk2 knockouts have more severe T cell development defects than Erkl knockout 
mice (Pages et al., 1999). However, we find that both Erkl and Erk2 contribute similarly to Erk 
activity as measured by the ability of Erk to phosphorylate myelin basic protein. The finding 
presented here could be explained by differences in some but not all Erkl and Erk2 
phosphorylation targets. However, of the known Erk phosphorylation targets, little is known 
about their isoform specificity. And although there have been attempts to identify additional Erk 
phosphorylation targets (Eblen et al., 2003; Lewis et al., 2000), these have not been determined 
to be isoform specific. 
By generating an epi-allelic series, which has been shown to be a useful tool for determining the 
effect of knocking down protein levels to various extents on phenotypic outcomes (Hemann et 
al., 2003), we have shown that an incomplete kinase knockdown can yield information 
consistent with the level to which the kinase is knocked-down. It remains to be seen whether 
these results are upheld for different proteins in multiple systems. However, it is of note, that the 
knockdown target, Erk, has been described as being ultrasensitive (Huang and Ferrell, 1996) or 
non-linearly related to the extracellular stimulus, and yet our results indicate that phenotypic 
outcome is not regulated by a steep threshold in knockdown levels. As ever increasing numbers 
of researchers rely on knockdown data generated from incomplete knockdowns, this work 
provides a framework for interpreting knockdown data in a consistent manner. 
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Figure 4.1. Generation of a range of stable knockdown cell lines 
A) Total Erk Western blot of the knockdown cell lines. Band intensities shown are normalized 
as described in text. Standard deviations reported include both experimental and biological 
replicates. B) Sum of Erkl and Erk2 is plotted against the fraction of either Erkl in an Erkl 
knockdown or Erk2 in an Erk2 knockdown. In the case of complete compensation by one 
isoform for the decreased levels of another, a horizontal line at y = 2 is expected. 
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Figure 4.2. Total Erk levels are related to IL-2 levels 
IL-2 levels following stimulation by 4ugImL L144 for 4 hours normalized to Luciferase control. 
IL-2 levels are plotted against total Erkl levels in an Erkl knockdown or total Erk2 in an Erk2 
knockdown. 
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Figure 4.3. Phospho Erk levels correlated with IL-2 
A) phospho-Erk levels as measured by Western blot of the knockdown cell lines following 
stimulation by 4uglmL L144 for 4 hours. Band intensities shown are normalized as described in 
text. Standard deviations reported include both experimental and biological replicates. B) For 
each knockdown cell line two data points are depicted: phospho Erkl level is plotted against 
total Erkl level and phospho Erk2 level is plotted against total Erk2 level. C) IL-2 levels 
normalized to control Luciferase IL-2 levels are plotted against phospho Erkl levels in an Erkl 
knockdown or phospho Erk2 in an Erk2 knockdown. 
n
o
rm
a
liz
ed
 E
rk
lI2
 a
c
tiv
ity
 
n
o
rm
a
liz
ed
 E
rk
lI2
 ac
tiv
ity
 
-
.
 
A
 
X 
g
z
z
b
b
 
CR
 
O
~
O
U
,
O
~
 
5. Conclusions and Future Directions 
Parallel and interconnected signaling pathways are activated downstream of T cell receptor 
binding to peptide MHC. Although the signaling events that occur as a result of TCR binding 
peptide MHC have been described, it is still unclear how the multiple pathways integrate to 
determine a specific cell fate. The goal of this work was to determine the predictive power on 
cell fate decisions of single pathways versus a combination of multiple pathways. The challenge 
of integrating information Erom multiple signaling pathways is not unique to the TCR. Many 
surface receptors, when bound, result in the activation of multiple signaling cascades. Therefore, 
this work has potential implications that are more broadly applicable to different systems. 
This thesis looks at whether there are master pathways activated that alone can determine cell 
fate or whether multiple pathways synergize to deterrnine cell fate. To answer this question, 
Melissa Kemp and I generated a data set of about 1 100 measurements representing both dynamic 
and multivariate information of TCR signaling in response to different avidity peptides. This 
data set was then analyzed using a linear regression model, PLSR. Our work shows that there 
are indeed pathways that, when perturbed, have the ability to modulate IL-2 levels. However, 
we find that no pathway alone is as correlated with IL-2 production as the combination of 
pathways. 
We tested the predictions generated by the model by using both inhibitors and shRNAs to down 
regulate the function of individual molecules. Akt inhibitors were used to show that Akt 
phosphorylation correlated linearly with IL-2 production as predicted by the model. Similarly, 
we show that Erk inhibition also correlated with IL-2 production. In addition, the model 
predicted that the combination of Erk and Akt inhibition would reduce IL-2 production by less 
than the sum of either inhibition alone, which was also verified experimentally. To further 
analyze the relationship between Erk levels and IL-2 production, shRNAs were generated that 
target either Erkl or Erk2. One surprising result of the ERK isoform knockdown experiments is 
that both isoforms appear to contribute equally to IL-2 production in this hybridoma cell lines. 
One potential limitation of this study is the scope of the predictive power of our model. Since 
the PLSR model is based on the state of network activation in a hybridoma cell line in response 
to TCR stimulation, it remains to be seen wether it can predict cellular responses in primary T 
cells, both mouse and human. Another limitation is the lack of mechanistic detail inherent in the 
model predictions. We have shown that certain molecules are critical for predicting IL-2 
production; Furthermore, we have shown that their activity correlates with IL-2 production. 
However, we have not been able to provide anything further than speculative mechanistic 
understanding of how these molecules govern IL-2 production. Further gains in our 
understanding of TCR ligand discrimination will be made by moving from a correlational to a 
more mechanistic understanding of the TCR network system. 
5.1. Determining T cell Fate 
Through analysis of the large signaling data set generated in the context of this study, a few key 
molecules were identified whose phosphorlyation states could predict IL-2 production in 
response to different avidity TCR signals. Both Akt and Erk phosphorylation levels were shown 
to be indicative of IL-2 production levels. 
It remains to be seen whether these same key molecules will be equally predictive of IL-2 
production in primary mouse T cells. In addition to looking at primary mouse T cells, one could 
investigate whether these observations also hold true in other species, such as primary human T 
cells. It may even be possible to determine, at the level of signaling molecules, the predictors of 
certain human disease states, such as autoimmune disease. It has been shown that CD4 T cell 
differentiation into either Thl or Th2 can determine the progression of multiple autoimmune 
diseases including EAE and diabetes (Nicholson and Kuchroo, 1996). Thl T cells produce 
inflammatory cytokines and have been shown to exacerbate autoimmune diseases while Th2 
cells have been shown to protect from autoimmune disease. By examining the network states 
that result in either the Thl or Th2 fate, one could identify the key signaling molecules that 
regulate the fate of CD4 T cells. By knowing the key regulators, drugs could potentially be used 
to direct the course of disease by coaxing cells from one fate to another. 
Co-stirnulatory molecules are known to be critical for determining pathogenic versus self 
peptides (Liu and Janeway, 1992). In this work, we were not able to determine the significance 
of co-stimulation on signaling dynamics since the 1B6 cells do not respond to CD28. However, 
determining the contributions of co-stirnulatory signals on T cell fate is possible using the 
methodology outlined here. In particular, one interesting question is whether co-stimulation 
activates additional pathways not activated by TCR signaling, or whether co-stimulation 
increases the magnitude of activated signals (Acuto et al., 2003). Current evidence suggests that 
CD28 contributes quantitatively to TCR signaling. However, a qualitative contribution cannot 
yet be ruled out. A systematic data collection and analysis approach would be able to suggest 
which of the above is more important for T cell activation in response to non-self peptides. 
Signals provided through the TCR are critical at multiple stages of T cell development in 
determining T cell fate. For example, signals provided by the preTCR at the DN3 stage signal a 
functional TCR rearrangement which results in T cell proliferation. Similarly, T cells are 
positively and negatively selected in the thymus based on the ability of the TCR to recognize and 
properly signal self-MHC peptide complexes (Starr et al., 2003). One interesting question is 
how the strength of the signal at different stages of T cell development - resulting in very 
different cell fates - is similar or different depending on the affinity of the TCR ligand. Are T 
cells capable of tuning their response to MHC peptide affinity through the process of selection in 
the thymus? There is evidence that T cells do in fact have different sensitivities as thymocytes 
and mature T cells (Davey et al., 1998). And if T cells are capable of tuning the response, by 
what mechanism do they do so? One possibility is that the number of receptors available at the 
cell surface is modified depending on the desired sensitivity of the T cell. Two lines of evidence 
could support this hypothesis: 1) it has been shown that the number of T cell receptors on the 
surface of T cells varies depending on the stage of T cell development (Roehm et al., 1984); 2) T 
cell receptors are internalized and degraded in response to a TCR stimulus (Valitutti et al., 1997). 
Another possible mechanism for tuning T cell sensitivity is by modifying the availability of 
downstream effector and signaling molecules. This kind of regulation could occur via 
transcriptional regulation. By using a systematic quantitative approach, one could measure, at 
different developmental stages, both the total number of signaling molecules, receptors, and their 
activation state in responses to different avidity ligands, to determine how T cells are capable of 
tuning their sensitivity to antigen. 
5.2. Further understanding of signaling molecules 
Through modeling and experiments, we have shown that Akt is a good predictor of IL-2 
production. The mechanism by which Akt might regulate IL-2 production is not entirely clear 
because Akt is not known to directly activate the known IL-2 transcription factors. However, 
Akt indirectly affects the signaling cascades leading to NF-KB, NFAT, and AP- 1 activation. 
NFAT nuclear translocation is enhanced by Akt-mediated inactivation of glycogen synthase 
kinase-3 (GSK3) thereby leading to a prolonged dephosphorylated and activated state of NFAT 
(Diehn et al., 2002). A recent report observed decreased shuttling of NFAT in murine T cells 
with constitutively active Akt (Patra et al., 2004). However, it is conceivable that long-term 
compensatory effects of upregulated Akt may lead to a desensitization of this mechanism; 
specifically, altered calcium dynamics in these cells may impact cytosolic dephosphorylation of 
NFAT synchronously with the lack of nuclear phosphorylation by GSK3. This same report also 
observed a decrease in NF-KB nuclear shuttling due to increased Akt levels. Other evidence 
suggests that Akt enhances NF-KB activation (Jones et al., 2005; Kane et al., 2001; Kane et al., 
1999) due to higher IK-B degradation rates (Jones et al., 2000). Finally, activation of the E W c -  
Fos pathway by PUK in a stimulus-strength dependent manner has been reported, but it is 
unclear if the observed effects are Akt-dependent (Schade and Levine, 2004). To determine 
through which signaling pathway i.e. NFAT, NFKB, or Erk Akt is exerting its effects on IL-2 
production, one could measure the activity of the transcription factors known to bind the IL-2 
promoter using commercially available reporter constructs. The change in transcription factor 
activity in the presence or absence of Akt inhibition would be a good indicator of the pathways 
being regulated by Akt activity. This approach could potentially elucidate the signaling 
pathways through which Akt is exerting its effect. Then, once an Akt target pathway has been 
identified, a more detailed study of the activation of individual molecules in the presence of an 
AM inhibitor may shed light on the molecular mechanism of Akt regulation. 
Knockouts have been generated for both Erkl and Erk2 and their T cell specific phenotypes have 
been determined (Pages et al., 1999; Saba-El-Lei1 et al., 2003). These genetic studies have 
shown that Erkl and Erk2 function non-redundantly, since Erk2 knockout mice die during 
embryogenesis, while Erkl knockout mice have only minor T cell defects. However, the 
molecular mechanism by which these two Erk isoforms uniquely contribute to cell fate has not 
been determined. In addition, data generated in Chapter 4 of this thesis indicates that Erkl and 
Erk2 are redundant pathways for transmitting the IL-2 response in the 1B6 hybridoma cell line. 
Given this finding, it would be interesting to investigate two potential mechanisms that could 
account for both redundancy and unique functions for Erk isoforms depending on the context of 
the experiment. First, Erk contributions could be cell type specific; second, Erk contributions 
could be substrate specific. To determine whether Erk contributions are cell type specific, the 
pheonotype of knocking down both Erk isoform individually would be examined in different cell 
lines and possibly cell fates. To determine whether Erk isoforms exhibit substrate specificity, 
Erk kinase assays would be performed in the knockdown cell lines reported here using multiple 
different, known Erk substrates. If in some cases the two Erk isoforms are substrate specific, 
Erk 1 knockdowns would be expected to behave differently form Erk2 knockdowns for kinase 
assays with certain Erk substrates but not with others. 
5.3. Conclusion 
This work provides a framework for analyzing how cells integrate and interpret information 
generated by an extracellular ligand bound to a receptor. Canonical signaling pathways are 
activated downstream of receptors, such as the MAPKs in the case of receptor tyrosine kinases 
and the Jak/Stat pathway in response to cytokine signaling. A diverse set of cell fates are elicited 
dependent on context of activation by extracellular ligands despite utilization of a common set of 
signaling pathways. Here, we show that the level of activation of single molecules, in the context 
of the entire signaling network, can modulate cell fate. We show that the activation level of Akt 
and Erk have predictable effects on cell fate. This suggests that each of these molecules provides 
a unique piece of information that is interpreted by the cell to make critical cell fate decisions. 
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Appendix A 
FENVALERATE, CYPERMETHRIN, DELTAMETHRIN, WRPHOSTIN 8 - Calcineurin (PP2B) inhibitors. 
KN-62, KN-93 - CaM kinase II inhibitors. 
2-HYDROXY-5-(2,5-DIHYDROXY BENZYLAMIN0)BENZOIC AClD - CAM Kinase II, EGF receptor tyrosine 
kinase, and pp60 kinase inhibitors. 
5,6-DICHLORO-1-beta-D-RIBOFURANOSYLBENZIMIDAZOLE - Casein kinase II inhibitor. 
RWJ-60475 - CD45 tyrosine phosphatase inhibitor. 
N9-ISOPROPYL-OLOMOUCINE - cdc2 kinase inhibitor. 
GW 5074 - cRAFl kinase inhibitor. 
INDIRUBIN-3'-MONOOXIME - Cyclin dependent kinase inhibitor. 
NRPHOSTIN 23, NRPHOSTIN 25, WRPHOSTIN 47, NRPHOSTIN 51, LAVENDUSTIN A, ERBSTATIN 
ANALOG, WRPHOSTIN AG 1478 - EGF receptor kinase inhibitors. 
NRPHOSTIN 46 - EGF receptor kinase, p56, and PDGF receptor kinase inhibitor. 
RG-14620 - EGFstimulated HER14 cell proliferation inhibitor. 
5-IODOTUBERCIDIN - ERK2, adenosine kinase, CK1, CK2, and insulin receptor kinase inhibitor. 
SU1498 - Flk-I kinase inhibitor. 
INDIRUBIN - GSK3beta and CDK5 inhibitor. 
AG-825 - HERI-2 tyrosine kinase inhibitor. 
BAY 1 1-7082 - I-kappa Balpha kinase inhibitor. 
HYDROXY-2-NAPHTHALENYL METHYLPHOSPHONIC AClD - Insulin receptor tyrosine kinase inhibitor. 
AG-490 - JAK-2 tyrosine kinase inhibitor. 
ZM 449829 - JAKS tyrosine kinase inhibitor. 
SP 600125 - Jun-N-terminal kinase inhibitor. 
LEVAMISOLE HCI, TETRAMISOLE HCI - Mammalian alkaline phosphatase inhibitors. 
PD-98059, U-0126 - MEK inhibitors. 
ML-7, ML-9 - MLC kinase inhibitors. 
OLOMOUCINE - p33 cdk2lcyclin A, p33 cdk2lcyclin E, p34 cdc21cyclin B, p33 cdk51p35 inhibitor. 
ROSCOVlTlNE - p34 cdc2lcyclin B kinase inhibitor. 
ZM 336372, SB-202190, SB-203580 - p38 MAP kinase inhibitors. 
DAMNACANTHAL - p56 tyrosine kinase inhibitor. 
2-AMINOPURINE - p58 PITSLRE beta1 inhibitor. 
AG-370, NRPHOSTIN 9, AG-1296 - PDGF receptor tyrosine kinase inhibitors. 
LY 294002, WORTMANNIN, QUERCETIN DIHYDRATE - PI 3-kinase inhibitor. 
H-8, HA-1004, HA-1077 - PKA and PKG inhibitors. 
H-89 - PKA inhibitor. 
STAUROSPORINE - PKA, PKG, CaMK, tyrosine kinases, and phosphorylase kinase inhibitors. 
H-7 - PKA, PKG, MLCK, and PKC inhibitor. 
ROTTLERIN - PKC delta inhibitor. 
SPHINGOSINE, Ro 31-8220, PALMITOYL-DL-CARNITINE CI - PKC inhibitors. 
2,2',3,3',4,4'-HEXAHYDROXY-1 ,I1-BIPHENYL-6,6'-DIMETHANOL DIMETHYL ETHER - PKCalpha and 
PKCgamma Inhibitor. 
CANTHARlDlC ACID, CANTHARIDIN - PP1 and PP2A inhibitors. 
ENDOTHALL - PP2A inhibitor. 
GF 109203X, HYPERICIN, H-9 - Protein kinase inhibitors. 
CinnGEL - PTPIB inhibitor. 
PP1, PP2 - Src tyrosine kinase inhibitors. 
PICEATANNOL - Syk inhibitor. 
AG-494, WRPHOSTIN AG 1288, WRPHOSTIN AG 1295, AG-126, AG-879, GENISTEIN, LFM-A13 - Tyrosine 
kinase inhibitors. 
BENNLPHOSPHONIC ACID, L-p-BROMOTETRAMISOLE OXALATE, RK-682 - Tyrosine phosphatase 
inhibitors. 
SU 4312 - VEGF receptor tyrosine kinase inhibitor. 
DAlDZElN - Negative control for Genistein. 
ISO-OLOMOUCINE - Negative control for olomoucine. 
WRPHOSTIN 1 - Negative control for tyrosine kinase inhibitors. 
Supplementary Fig. 1 
List of kinase and phosphatase inhibitors screened for their ability to inhibit IL-2 
production in human H9 T cells. 
CONC. 
(PM) 
IL-2 Conc. 
(ng/ml) 
% of Control 
IL-2 INHIBITOR INHIBITION TARGET 
stimulated Control 
unstimulated Control 
PP1 
BAY 1 1-7082 
HYPERlClN 
U-0126 
stimulated Control 
unstimulated Control 
Src family tyrosine kinase inhibitor. 
I-kappa B-alpha kinase inhibitor. 
Protein kinase C inhibitor. 
MEK inhibitor. 
Phosphatidylinositol 3-kinase 
inhibitor. LY 294002 
SP 600125 
AG-879 
CYPERMETHRIN 
PD-98059 
RO 31-8220 
Jun-N-terminal kinase inhibitor 
Tyrosine kinase inhibitor. 
Calcineurin (PP2B) inhibitor 
MAP kinase inhibitor. 
Protein kinase C inhibitor. 
TYRPHOSTIN AG 1296 
2,2',3,3',4,4'-HEXAHYDROXY-I , 1'- 
BIPHENYL-6,6'-DIMETHANOL 
DIMETHYL ETHER 
PPZ 
PALMITOYL-DL-CARNITINE CI 
SB-202190 
DELTAMETHRIN 
Tyrosine kinase inhibitor. 
PKCalpha and PKCgamma Inhibitor. 
Src tyrosine kinase inhibitor. 
PKC inhibitor. 
p38 MAP kinase inhibitor 
Calcineurin (PP2B) inhibitor. 
Phosphatidylinositol 3-kinase 
inhibitor. WORTMANNIN 
PKA inhibitor. 
p38 mitogen-activated protein kinase 
inhibitor. 
Calcineurin inhibitor. TYRPHOSTIN 8 
RK-682 
KN-93 
KN-62 
Tyrosine phosphatase inhibitor 
CaM kinase II inhibitor. 
CAM Kinase II inhibitor. 
Supplementary Fig. 2 
List of kinase and phosphatase inhibitors screened for their ability to inhibit IL-2 
production in 1 B6 cells. Inhibitors used at concentrations indicated. 
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Supplementary Fig. 1 
FACS analysis of AnnexinV-PI stained 1B6 cells stimulated with PLP altered peptide 
ligands. 
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Supplementary Fig. 2 
(A) The PLSR algorithm converges at 2 principal components, resulting in a regression 
coefficient of 0.94 for the IL-2 data. Illustrated is the cumulative regression coefficient 
and cumulative fraction of the total variation in IL-2 that can be predicted by each 
component. The components beyond the second are not significant and shown only for 
illustrative purposes. (B) Complete loading plot of all X variables used in the model, 
projected with IL-2. Coloring is as follows: IL-2, red diamond; Akt, light green; Erkl, 
lavender; ERJK.2, dark purple; IKK, orange; JNKI, navy; JNK2, blue; JNK3, cyan; 
cytosolic NFAT, light pink; nuclear NFAT, dark pink; MK2, dark green; p38, brown. 
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Supplementary Fig. 3 
(A) Western blot of ERK, JNK, p38 and Akt phosphorylation in DAS cell lysates during 
co-culture with lB6 cells (B) IL-2 production in 1B6 cells from 4 pglml L 144 peptide 
stimulus with and without CTLA-4/Fc chimera fusion protein (R & D Systems). (C) 
activation-induced apoptosis due to plate-bound antiCD3 stimulation with and without 
soluble antiCD28. Error bars represent +I- standard deviation. 
Supplementary Fig. 4 
Generation of dose resonse curves for inhibitors. Representative western blot and dose 
response curves based upon triplicate measurements. 1 B6 cells were preincubated with 
inhibitor for 30 minutes with PD98059 (A) or LY294002 (B) prior to stimulation with 
DAS cells loaded with 4 pglml L144. Cells were lysed at 30 minutes for western blotting 
or supernatant collected at 4 hours for IL-2 measurements. Dose response curves 
represent triplicate experiments +/- standard deviation and fitted to a function of the form 
y=ab/(b+x). 
Supplementary Fig. 5 
Reduced models as described in Fig. 5 are compared in their ability to predict IL-2 as in 
Fig. 6. (A) ERIC112 only or ERK1,2 + Akt only models superimposed with the data fiom 
Fig. 6B. (B) Akt only or Akt + ERK1/2 only models superimposed with the data from 
Fig. 6D. 
